<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>One dose per day compared to multiple doses per day of gentamicin for treatment of suspected or proven sepsis in neonates - Rao, SC - 2016 | Cochrane Library</title> <meta content="One dose per day compared to multiple doses per day of gentamicin for treatment of suspected or proven sepsis in neonates - Rao, SC - 2016 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD005091.pub4/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="One dose per day compared to multiple doses per day of gentamicin for treatment of suspected or proven sepsis in neonates - Rao, SC - 2016 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD005091.pub4/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD005091.pub4" name="dc.identifier" scheme="DOI"/> <meta content="One dose per day compared to multiple doses per day of gentamicin for treatment of suspected or proven sepsis in neonates" name="citation_title"/> <meta content="Shripada C Rao" name="citation_author"/> <meta content="King Edward Memorial Hospital for Women and Princess Margaret Hospital for Children" name="citation_author_institution"/> <meta content="Shripada.Rao@health.wa.gov.au" name="citation_author_email"/> <meta content="Ravisha Srinivasjois" name="citation_author"/> <meta content="University of Western Australia, Joondalup Health Campus" name="citation_author_institution"/> <meta content="Kwi Moon" name="citation_author"/> <meta content="Princess Margaret Hospital for Children" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="12" name="citation_issue"/> <meta content="10.1002/14651858.CD005091.pub4" name="citation_doi"/> <meta content="2016" name="citation_date"/> <meta content="2016/12/06" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD005091.pub4/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD005091.pub4/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD005091.pub4/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Anti‐Bacterial Agents [*administration &amp; dosage, adverse effects, pharmacokinetics]; Drug Administration Schedule; Gentamicins [*administration &amp; dosage, adverse effects, pharmacokinetics]; Hearing [drug effects]; Kidney [drug effects]; Randomized Controlled Trials as Topic; Sepsis [*drug therapy, metabolism]" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005091.pub4&amp;doi=10.1002/14651858.CD005091.pub4&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005091.pub4&amp;doi=10.1002/14651858.CD005091.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005091.pub4&amp;doi=10.1002/14651858.CD005091.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005091.pub4&amp;doi=10.1002/14651858.CD005091.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005091.pub4&amp;doi=10.1002/14651858.CD005091.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005091.pub4&amp;doi=10.1002/14651858.CD005091.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005091.pub4&amp;doi=10.1002/14651858.CD005091.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005091.pub4&amp;doi=10.1002/14651858.CD005091.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005091.pub4&amp;doi=10.1002/14651858.CD005091.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005091.pub4&amp;doi=10.1002/14651858.CD005091.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005091.pub4&amp;doi=10.1002/14651858.CD005091.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005091.pub4&amp;doi=10.1002/14651858.CD005091.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005091.pub4&amp;doi=10.1002/14651858.CD005091.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005091.pub4&amp;doi=10.1002/14651858.CD005091.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005091.pub4&amp;doi=10.1002/14651858.CD005091.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005091.pub4&amp;doi=10.1002/14651858.CD005091.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005091.pub4&amp;doi=10.1002/14651858.CD005091.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005091.pub4&amp;doi=10.1002/14651858.CD005091.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005091.pub4&amp;doi=10.1002/14651858.CD005091.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005091.pub4&amp;doi=10.1002/14651858.CD005091.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005091.pub4&amp;doi=10.1002/14651858.CD005091.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005091.pub4&amp;doi=10.1002/14651858.CD005091.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005091.pub4&amp;doi=10.1002/14651858.CD005091.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773519000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773548000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000"}};Liferay.authToken="0TJL4CWK";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD005091\x2epub4\x26doi\x3d10\x2e1002\x2f14651858\x2eCD005091\x2epub4\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005091\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD005091\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513680837000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","ru","pt","pl","fa"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD005091.pub4",title:"One dose per day compared to multiple doses per day of gentamicin for treatment of suspected or proven sepsis in neonates",firstPublishedDate:"Dec 6, 2016 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Neonatal Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734739000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=0TJL4CWK&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD005091.pub4&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD005091.pub4';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD005091.pub4/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD005091.pub4/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD005091.pub4%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD005091.pub4/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD005091.pub4/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD005091.pub4/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD005091.pub4/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD005091.PUB4" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;pt&quot;,&quot;title&quot;:&quot;Resumo&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;pl&quot;,&quot;title&quot;:&quot;Streszczenie prostym językiem&quot;},{&quot;language&quot;:&quot;pt&quot;,&quot;title&quot;:&quot;Resumo para leigos&quot;},{&quot;language&quot;:&quot;ru&quot;,&quot;title&quot;:&quot;Резюме на простом языке&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD005091.pub4/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD005091.PUB4" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD005091.pub4/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD005091.pub4/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>5856 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD005091.pub4" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005091.pub4/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005091.pub4/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005091.pub4/full#CD005091-abs-0004"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005091.pub4/full#CD005091-sec-0087"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005091.pub4/full#CD005091-sec-0022"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005091.pub4/full#CD005091-sec-0023"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005091.pub4/full#CD005091-sec-0028"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005091.pub4/full#CD005091-sec-0029"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005091.pub4/full#CD005091-sec-0052"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005091.pub4/full#CD005091-sec-0081"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD005091.pub4/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005091.pub4/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005091.pub4/appendices#CD005091-sec-0092"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005091.pub4/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005091.pub4/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD005091.pub4/media/CDSR/CD005091/table_n/CD005091StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD005091.pub4/media/CDSR/CD005091/table_n/CD005091StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005091.pub4/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005091.pub4/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005091.pub4/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD005091.pub4/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD005091.pub4/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD005091.pub4/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2017 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD005091.pub4/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">One dose per day compared to multiple doses per day of gentamicin for treatment of suspected or proven sepsis in neonates </h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD005091.pub4/information#CD005091-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Shripada C Rao</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD005091.pub4/information#CD005091-cr-0003">Ravisha Srinivasjois</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD005091.pub4/information#CD005091-cr-0004">Kwi Moon</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD005091.pub4/information/en#CD005091-sec-0097">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 06 December 2016 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD005091.pub4/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD005091.pub4">https://doi.org/10.1002/14651858.CD005091.pub4</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD005091-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD005091-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD005091-abs-0003">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD005091-abs-0009">فارسی</a> </li> <li class="section-language"> <a class="" href="full/pt#CD005091-abs-0002">Português</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD005091-abs-0001" lang="en"> <section id="CD005091-sec-0001"> <h3 class="title" id="CD005091-sec-0001">Background</h3> <p>Animal studies and trials in older children and adults suggest that a 'one dose per day' regimen of gentamicin is superior to a 'multiple doses per day' regimen. </p> </section> <section id="CD005091-sec-0002"> <h3 class="title" id="CD005091-sec-0002">Objectives</h3> <p>To compare the efficacy and safety of one dose per day compared to multiple doses per day of gentamicin in suspected or proven sepsis in neonates. </p> </section> <section id="CD005091-sec-0003"> <h3 class="title" id="CD005091-sec-0003">Search methods</h3> <p>Eligible studies were identified by searching the Cochrane Central Register of Controlled Trials (CENTRAL; 2016, Issue 3) in the Cochrane Library (searched 8 April 2016), MEDLINE (1966 to 8 April 2016), Embase (1980 to 8 April 2016), and CINAHL (December 1982 to 8 April 2016). </p> </section> <section id="CD005091-sec-0004"> <h3 class="title" id="CD005091-sec-0004">Selection criteria</h3> <p>All randomised or quasi‐randomised controlled trials comparing one dose per day ('once a day') compared to multiple doses per day ('multiple doses a day') of gentamicin to newborn infants. </p> </section> <section id="CD005091-sec-0005"> <h3 class="title" id="CD005091-sec-0005">Data collection and analysis</h3> <p>Data collection and analysis was performed according to the standards of the Cochrane Neonatal Review Group. </p> </section> <section id="CD005091-sec-0006"> <h3 class="title" id="CD005091-sec-0006">Main results</h3> <p>Eleven RCTs were included (N = 574) and 28 excluded. All except one study enrolled infants of more than 32 weeks' gestation. Limited information suggested that infants in both 'once a day' as well as 'multiple doses a day' regimens showed adequate clearance of sepsis (typical RR 1.00, 95% CI 0.84 to 1.19; typical RD 0.00, 95% CI −0.19 to 0.19; 3 trials; N = 37). 'Once a day' gentamicin regimen was associated with fewer failures to attain peak level of at least 5 µg/ml (typical RR 0.22, 95% CI 0.11 to 0.47; typical RD −0.13, 95% CI −0.19 to −0.08; number needed to treat for an additional beneficial outcome (NNTB) = 8; 9 trials; N = 422); and fewer failures to achieve trough levels of 2 µg/ml or less (typical RR 0.38, 95% CI 0.27 to 0.55; typical RD −0.22, 95% CI −0.29 to −0.15; NNTB = 4; 11 trials; N = 503). 'Once a day' gentamicin achieved higher peak levels (MD 2.58, 95% CI 2.26 to 2.89; 10 trials; N = 440) and lower trough levels (MD −0.57, 95% CI −0.69 to −0.44; 10 trials; N = 440) than 'multiple doses a day' regimen. There was no significant difference in ototoxicity between two groups (typical RR 1.69, 95% CI 0.18 to 16.25; typical RD 0.01, 95% CI −0.04 to 0.05; 5 trials; N = 214). Nephrotoxicity was not noted with either of the treatment regimens. Overall, the quality of evidence was considered to be moderate on GRADE analysis, given the small sample size and unclear/high risk of bias in some of the domains in a few of the included studies. </p> </section> <section id="CD005091-sec-0007"> <h3 class="title" id="CD005091-sec-0007">Authors' conclusions</h3> <p>There is insufficient evidence from the currently available RCTs to conclude whether a 'once a day' or a 'multiple doses a day' regimen of gentamicin is superior in treating proven neonatal sepsis. However, data suggest that pharmacokinetic properties of a 'once a day' gentamicin regimen are superior to a 'multiple doses a day' regimen in that it achieves higher peak levels while avoiding toxic trough levels. There was no change in nephrotoxicity or auditory toxicity. Based on the assessment of pharmacokinetics, a 'once a day regimen' may be superior in treating sepsis in neonates of more than 32 weeks' gestation. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD005091-abs-0004" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD005091-abs-0004">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD005091-abs-0008">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD005091-abs-0010">فارسی</a> </li> <li class="section-language"> <a class="" href="full/pl#CD005091-abs-0007">Polski</a> </li> <li class="section-language"> <a class="" href="full/pt#CD005091-abs-0006">Português</a> </li> <li class="section-language"> <a class="" href="full/ru#CD005091-abs-0005">Русский</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD005091-abs-0004" lang="en"> <h3>Gentamicin dosage in neonates</h3> <p><b>Background:</b> Gentamicin is a commonly used antibiotic that is very effective in treating bacterial infections in newborn babies. </p> <p><b>Review question:</b> Whether giving the full dose of gentamicin as a single dose per day is better than giving it as multiple small doses in a day in newborn babies. </p> <p><b>Study characteristics:</b> Eleven scientific studies were analysed to derive the best available evidence. The majority of the studies included newborn babies born after 32 weeks' gestation. The main outcomes assessed were drug levels in the blood and kidney functions. The search was updated to 29 April 2016. </p> <p><b>Key results:</b> Safer and potentially more effective levels of the drug were maintained using a 'one dose per day' treatment schedule. No differences in the risk of adverse effects on the kidney function or hearing were noted between two regimens. </p> <p><b>Quality of evidence:</b> The quality was evidence was considered as moderate because the sample size was relatively small and two of the studies were scientifically less robust. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD005091-sec-0087" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD005091-sec-0087"></div> <h3 class="title" id="CD005091-sec-0088">Implications for practice</h3> <section id="CD005091-sec-0088"> <p>There is insufficient evidence from the currently available RCTs to conclude whether a 'once a day' or a 'multiple doses a day' regimen of gentamicin is superior in treating bacteriologically confirmed neonatal sepsis. However, the pharmacokinetic properties of a 'once a day' gentamicin regimen are superior to 'multiple doses a day' gentamicin in that it achieves higher peak levels while avoiding toxic trough levels. There appear to be no differences in nephrotoxicity or auditory toxicity. Hence a 'once a day' regimen may be superior in treating neonatal sepsis in neonates of more than 32 weeks' gestation. </p> </section> <h3 class="title" id="CD005091-sec-0089">Implications for research</h3> <section id="CD005091-sec-0089"> <p>Studies comparing the 'multiple doses per day' and 'one dose per day' regimens for microbiologically confirmed sepsis requiring prolonged antibiotic therapy need to be done to confirm if the pharmacokinetic benefits translate into clinical efficacy and safety. It is also important to follow such neonates long term to find out the effects on hearing and speech. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD005091-sec-0022" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD005091-sec-0022"></div> <div class="table" id="CD005091-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span><span class="table-title"></span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>One dose per day compared with multiple doses per day of gentamicin for treatment of suspected or proven sepsis in neonates</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population: neonates</b> with suspected or proven sepsis </p> <p><b>Settings: neonatal intensive care units</b> </p> <p><b>Intervention: one dose per day gentamicin</b> </p> <p><b>Comparison: multiple doses per day gentamicin</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of Participants<br/> (studies)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Multiple doses per day of gentamicin</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>One dose per day gentamicin</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Clearance of proven</b> </p> <p><b>sepsis</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Actual risk: 17 per 17</b> </p> <p><b>(1000 per 1000)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Actual risk: 20 per 20</b> </p> <p><b>(1000 per 1000)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1</b>(0.84 to 1.19) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>37</p> <p>(3 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Very small sample size, high risk of bias in the domain of completeness of follow‐up in 2 studies, high risk of bias for random sequence generation and allocation concealment in one study. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Failure to</b> </p> <p><b>achieve peak levels of at least 5 microgram/ml</b> </p> <p>(measured 0.5 to one hour after administration of any dose of gentamicin)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Actual risk: 35 per 214</b> </p> <p><b>(164 per 1000)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Actual risk:</b> </p> <p><b>6 per 208</b> </p> <p><b>(29 per 1000)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.22 (0.11 to 0.47)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>422</p> <p>(9 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate sample size, high risk of selection bias in two studies; high risk of attrition bias in 3 studies. </p> <p>Narrow CIs around the effect size, very low P value for effect size</p> <p>estimate, no statistical heterogeneity</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Nephrotoxicity</b> </p> <p>(End of study period or before discharge)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>348</p> <p>(8 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None of the study infants developed nephrotoxicity.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Ototoxicity</b> </p> <p>(End of study period or before discharge)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Actual risk: 1 per 111</b> </p> <p><b>(9 per 1000)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Actual risk:</b> </p> <p><b>2 per 103</b> </p> <p><b>(19 per 1000)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.69</b> ( <b>0.18 to 16.25 )</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>214</p> <p>(5 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Small sample size. Unclear risk of selection bias and reporting bias and high risk of attrition bias in the included studies. </p> <p>Wide CIs around the effect size, P value for effect size is greater than 0.05.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Failure to</b> </p> <p><b>achieve trough levels of</b> ≤<b>2 microgram/ml</b> </p> <p>(measured within one hour prior to the administration of gentamicin on any day except the initial dose) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Actual risk: 92 per 259</b> </p> <p><b>(355 per 1000)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Actual risk: 31/244</b> </p> <p><b>(127 per 1000)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.38</b> </p> <p><b>(</b>0.27 to 0.55) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>503 (11 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate sample size, high risk of selection bias in 2 studies, high risk of attrition bias in 3 studies, high risk of reporting bias in 2 studies. </p> <p>Narrow CIs around the effect size, very low P value for effect size estimate, moderate heterogeneity </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk Ratio; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD005091-sec-0023" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD005091-sec-0023"></div> <section id="CD005091-sec-0024"> <h3 class="title" id="CD005091-sec-0024">Description of the condition</h3> <p>Gentamicin, an aminoglycoside antibiotic, is widely used in the treatment of suspected or proven bacterial sepsis in newborn infants. It is rapidly bactericidal. Combined with beta‐lactam antibiotics, it provides synergistic activity against the most commonly encountered pathogens in the neonatal period (<a href="./references#CD005091-bbs2-0049" title="ChattopadhyayB . Newborns and gentamicin‐‐how much and how often?. Journal of Antimicrobial Chemotherapy2002;49(1):13‐6. ">Chattopadhyay 2002</a>). Potential ototoxicity and nephrotoxicity has been linked to the drug levels in plasma. Higher trough concentrations are associated with drug toxicity (<a href="./references#CD005091-bbs2-0091" title="SwanSK . Aminoglycoside nephrotoxicity. Seminars in Nephrology1997;17(1):27‐33. ">Swan 1997</a>); and lower peak levels are associated with lesser efficacy (<a href="./references#CD005091-bbs2-0073" title="KovarikJM , HoepelmanIM , VerhoefJ . Once‐daily aminoglycoside administration: new strategies for an old drug. European Journal of Clinical Microbiology &amp; Infectious Diseases1989;8(9):761‐9. ">Kovarik 1989</a>; <a href="./references#CD005091-bbs2-0048" title="ChambersHF . The aminoglycosides. Goodman and Gillman's The pharmacological basis of therapeutics. McGraw‐Hill Professional, 2001. ">Chambers 2001</a>). The bactericidal effect of gentamicin is concentration dependent; the higher the concentration, the greater the bactericidal effect. Generally accepted peak concentrations are 5 to 10 µg/ml. It has been suggested that even higher peak levels (e.g. 25 µg per ml) do not increase the risk of toxicity (<a href="./references#CD005091-bbs2-0048" title="ChambersHF . The aminoglycosides. Goodman and Gillman's The pharmacological basis of therapeutics. McGraw‐Hill Professional, 2001. ">Chambers 2001</a>). It is also suggested that the trough concentrations should be less than 1 to 2 µg/ml to minimise the toxic effects (<a href="./references#CD005091-bbs2-0048" title="ChambersHF . The aminoglycosides. Goodman and Gillman's The pharmacological basis of therapeutics. McGraw‐Hill Professional, 2001. ">Chambers 2001</a>). Increasing the interval between doses has the potential to maintain maximal bactericidal activity, while minimizing the side effects. </p> </section> <section id="CD005091-sec-0025"> <h3 class="title" id="CD005091-sec-0025">Description of the intervention</h3> <p>Several concepts support the benefit of a treatment regime that administers one dose per day ('once a day' dose) of gentamicin (<a href="./references#CD005091-bbs2-0008" title="MironD , SteinfeldM , HasaneinJ , FelszerC , ReichD . Tolerability of once‐daily‐dosing of intravenous gentamicin in preterm neonates born at 32‐37 weeks of gestation. Harefuah2003;142(6):413‐5. ">Miron 2003</a>). </p> <p> <ol id="CD005091-list-0001"> <li> <p>Gentamicin exhibits a concentration‐dependent bactericidal effect in which a positive linear relationship exists between the peak minimum inhibitory concentration (MIC) ratio and bactericidal response. </p> </li> <li> <p>Gentamicin exhibits the post‐antibiotic effect (PAE). The PAE is a period during which the antibiotic continues to suppress bacterial growth despite serum concentrations below the MIC (<a href="./references#CD005091-bbs2-0070" title="KahlmeterG , DahlagerJI . Aminoglycoside toxicity ‐ a review of clinical studies published between 1975 and 1982. Journal of Antimicrobial Chemotherapy1984;13 Suppl A:9‐22. ">Kahlmeter 1984</a>; <a href="./references#CD005091-bbs2-0048" title="ChambersHF . The aminoglycosides. Goodman and Gillman's The pharmacological basis of therapeutics. McGraw‐Hill Professional, 2001. ">Chambers 2001</a>). A prolonged PAE requires high peak concentrations and is associated with better clinical response. Because a 'once a day' dose produces higher peak drug concentrations, it results in a prolonged PAE (<a href="./references#CD005091-bbs2-0053" title="CraigWA . Once‐daily versus multiple‐daily dosing of aminoglycosides. Journal of Chemotherapy1995;7 suppl 2:47‐52. ">Craig 1995</a>). </p> </li> <li> <p>One of the first steps in the uptake of aminoglycoside into sites of toxicity is their binding to the brush borders of renal cells and to the cochlea and vestibular membranes. Uptake by these tissues is more efficient with low sustained concentrations compared to high intermittent levels. Animal models suggest that uptake of gentamicin in the renal cortex and perilymph is a saturable process that is relatively unaffected by drug concentration; transient high peak levels do not lead to excessive drug accumulation (<a href="./references#CD005091-bbs2-0061" title="GiulianoRA , VerpootenGA , VerbistL , WedeenRP , DeBroeME . In vivo uptake kinetics of aminoglycosides in the kidney cortex of rats. Journal of Pharmacology and Experimental Therapeutics1986;236(2):470‐5. ">Giuliano 1986</a>; <a href="./references#CD005091-bbs2-0095" title="VerpootenGA , GiulianoRA , VerbistL , EestermansG , DeBroeME . Once‐daily dosing decreases renal accumulation of gentamicin and netilmicin. Clinical Pharmacology and Therapeutics1989;45(1):22‐7. ">Verpooten 1989</a>; <a href="./references#CD005091-bbs2-0045" title="BeaubienAR , OrmsbyE , BayneA , CarrierK , CrossfieldG , DownesM , et al. Evidence that amikacin ototoxicity is related to total perilymph area under the concentration‐time curve regardless of concentration. Antimicrobial Agents and Chemotherapy1991;35(6):1070‐4. ">Beaubien 1991</a>). 'Once a day' dosing of aminoglycoside has been shown to be less toxic and more efficacious than more frequent dosing in animal models and observational studies in human neonates (<a href="./references#CD005091-bbs2-0053" title="CraigWA . Once‐daily versus multiple‐daily dosing of aminoglycosides. Journal of Chemotherapy1995;7 suppl 2:47‐52. ">Craig 1995</a>; <a href="./references#CD005091-bbs2-0054" title="DarmstadtGL , HossainMM , JanaAK , SahaSK , ChoiY , SridharS , et al. Determination of extended‐interval gentamicin dosing for neonatal patients in developing countries. Pediatric Infectious Disease Journal2007;26(6):501‐7. ">Darmstadt 2007</a>; <a href="./references#CD005091-bbs2-0055" title="DarmstadtGL , Miller‐BellM , BatraM , LawP , LawK . Extended‐interval dosing of gentamicin for treatment of neonatal sepsis in developed and developing countries. Journal of Health, Population, and Nutrition2008;26:163‐82. ">Darmstadt 2008</a>; <a href="./references#CD005091-bbs2-0037" title="ThingvollES , GuilletR , CasertaM , DicenzoR . Observational trial of a 48‐hour gentamicin dosing regimen derived from Monte Carlo simulations in infants born at less than 28 weeks' gestation. Journal of Pediatrics2008;153(4):530‐4. ">Thingvoll 2008</a>; <a href="./references#CD005091-bbs2-0046" title="BeggEJ , Vella‐BrincatJW , RobertshaweB , McMurtrieMJ , KirkptrickCM , DarlowB . Eight years' experience of an extended‐interval dosing protocol for gentamicin in neonates. Journal of Antimicrobial Chemotherapy2009;63(5):1043‐9. ">Begg 2009</a>; <a href="./references#CD005091-bbs2-0018" title="HagenI , OymerK . Pharmacological differences between once and twice daily gentamicin dosage in newborns with suspected sepsis. Pharmacy World and Science2009;31(1):18‐23. ">Hagen 2009</a>). </p> </li> <li> <p>Adaptive resistance is thought to occur after continuous exposure of bacteria to antibiotic concentrations that are less than the MIC (<a href="./references#CD005091-bbs2-0075" title="LacyMK , NicolauDP , NightingaleCH , QuintilianiR . The pharmacodynamics of aminoglycosides. Clinical Infectious Diseases1998;27(1):23‐7. ">Lacy 1998</a>). 'Once a day' dosing may help to avoid the development of resistance by achieving a higher bacterial kill initially, thereby decreasing the length of time viable bacteria are in contact with the drug. </p> </li> <li> <p>Neonates, especially sick infants, have low glomerular filtration rate (<a href="./references#CD005091-bbs2-0041" title="AperiaA , BrobergerO , ElinderG , HerinP , ZetterstromR . Postnatal development of renal function in pre‐term and full‐term infants. Acta Paediatrica Scandinavia1981;70(2):183‐7. ">Aperia 1981</a>; <a href="./references#CD005091-bbs2-0094" title="VanpéeM , ErganderU , HerinP , AperiaA . Renal function in sick, very low‐birth‐weight infants. Acta Paediatrica1993;82(9):714‐8. ">Vanpée 1993</a>; <a href="./references#CD005091-bbs2-0088" title="SonntagJ , PrankelB , WaltzS . Serum creatinine concentration, urinary creatinine excretion and creatinine clearance during the first 9 weeks in preterm infants with a birth weight below 1500 g. European Journal of Pediatrics1996;155(9):815‐9. ">Sonntag 1996</a>; <a href="./references#CD005091-bbs2-0059" title="GalliniF , MaggioL , RomagnoliC , MarroccoG , TortoroloG . Progression of renal function in preterm neonates with gestational age &lt; or = 32 weeks. Pediatric Nephrology2000;15(1‐2):119‐24. ">Gallini 2000</a>), which leads to slower clearance and higher volume of distribution of drugs like gentamicin (<a href="./references#CD005091-bbs2-0083" title="NielsenEI , SandströmM , HonoréPH , EwaldU , FribergLE . Developmental pharmacokinetics of gentamicin in preterm and term neonates: population modelling of a prospective study. Clinical Pharmacokinetics2009;48(4):253‐63. ">Nielsen 2009</a>). 'Once a day' dosing, by providing more time for clearance, may avoid the toxic effects of gentamicin due to slower clearance (<a href="./references#CD005091-bbs2-0046" title="BeggEJ , Vella‐BrincatJW , RobertshaweB , McMurtrieMJ , KirkptrickCM , DarlowB . Eight years' experience of an extended‐interval dosing protocol for gentamicin in neonates. Journal of Antimicrobial Chemotherapy2009;63(5):1043‐9. ">Begg 2009</a>). </p> </li> <li> <p>Pharmacokinetics of drugs in neonates are unique and greatly influenced by gestational age and birth weight, postnatal age, postconceptional age and renal function (<a href="./references#CD005091-bbs2-0083" title="NielsenEI , SandströmM , HonoréPH , EwaldU , FribergLE . Developmental pharmacokinetics of gentamicin in preterm and term neonates: population modelling of a prospective study. Clinical Pharmacokinetics2009;48(4):253‐63. ">Nielsen 2009</a>; <a href="./references#CD005091-bbs2-0085" title="PacificiGM . Clinical pharmacokinetics of aminoglycosides in the neonate: a review. European Journal of Clinical Pharmacology2009;65:419‐27. ">Pacifici 2009</a>; <a href="./references#CD005091-bbs2-0033" title="SeraneTV , ZengeyaS , PenfordG , CookeJ , KhannaG , McGregor‐ColmanE . Once daily dose gentamicin in neonates ‒ is our dosing correct?. Acta Paediatrica2009;98(7):1100‐5. ">Serane 2009</a>). It may be ideal to use customised dosing for infants based on the gentamicin pharmacokinetics in each infant (<a href="./references#CD005091-bbs2-0092" title="TouwDJ , WestermanEM , SprijAJ . Therapeutic drug monitoring of aminoglycosides in neonates. Clinical Pharmacokinetics2009;48(2):71‐88. ">Touw 2009</a>). However, this involves frequent measurement of serum gentamicin levels and rewriting of the medication orders with the potential for prescription errors. The majority of the use of gentamicin in the neonatal population is for the treatment of infants with risk factors for sepsis pending culture results for a short period of 48 to 72 hours. If a 'once a day' regimen attains adequate peak levels while avoiding toxic trough levels, then frequent measurement of serum gentamicin levels may not be necessary in these short (72 hour) 'rule out sepsis' courses. This would significantly reduce the hospital cost associated with gentamicin therapy (<a href="./references#CD005091-bbs2-0082" title="NicolauDP , WuAH , FinocchiaroS , UdehE , ChowMS , QuintilianiR , et al. Once‐daily aminoglycoside dosing: impact on requests and costs for therapeutic drug monitoring. Therapeutic Drug Monitoring1996;18(3):263‐6. ">Nicolau 1996</a>; <a href="./references#CD005091-bbs2-0069" title="HittCM , KlepserME , NightingaleCH , QuintilianiR , NicolauDP . Pharmacoeconomic impact of once‐daily aminoglycoside administration. Pharmacotherapy1997;17(4):810‐4. ">Hitt 1997</a>; <a href="./references#CD005091-bbs2-0011" title="ThureenPJ , ReiterPD , GresoresA , StolpmanNM , KawatoK , HallDM . Once‐ versus twice‐daily gentamicin dosing in neonates &gt;=34 weeks' gestation: cost‐effectiveness analyses. Pediatrics1999;103(3):594‐8. ">Thureen 1999</a>). </p> </li> </ol> </p> </section> <section id="CD005091-sec-0026"> <h3 class="title" id="CD005091-sec-0026">How the intervention might work</h3> <p>Meta analyses of studies in adults have consistently shown that once‐daily dosing of aminoglycoside including gentamicin is as effective as multiple daily dosing, with similar or lesser risk of nephrotoxicity and ototoxicity (<a href="./references#CD005091-bbs2-0044" title="BarzaM , IoannidisJP , CappelleriJC , LauJ . Single or multiple daily doses of aminoglycosides: a meta‐analysis. BMJ1996;312(7027):338‐45. ">Barza 1996</a>; <a href="./references#CD005091-bbs2-0080" title="MunckhofWJ , GraysonML , TurnidgeJD . A meta‐analysis of studies on the safety and efficacy of aminoglycosides given either once daily or as divided doses. Journal of Antimicrobial Chemotherapy1996;37(4):645‐63. ">Munckhof 1996</a>; <a href="./references#CD005091-bbs2-0040" title="AliMZ , GoetzMB . A meta‐analysis of the relative efficacy and toxicity of single daily dosing versus multiple daily dosing of aminoglycosides. Clinical Infectious Diseases1997;24(5):796‐809. [PUBMED: 9142772] ">Ali 1997</a>; <a href="./references#CD005091-bbs2-0042" title="BaileyTC , LittleJR , LittenbergB , ReichleyRM , DunaganWC . A meta‐analysis of extended‐interval dosing versus multiple daily dosing of aminoglycosides. Clinical Infectious Diseases1997;24(5):786‐95. ">Bailey 1997</a>; <a href="./references#CD005091-bbs2-0068" title="HatalaR , DinhTT , CookDJ . Single daily dosing of aminoglycosides in immunocompromised adults: a systematic review. Clinical Infectious Diseases1997;24(5):810‐5. ">Hatala 1997</a>). </p> <p>A systematic review of similar studies in children and infants concluded that a 'once a day' regimen is more efficacious and has no higher toxicity compared with multiple daily dosing (<a href="./references#CD005091-bbs2-0079" title="MironD . Once daily dosing of gentamicin in infants and children. Pediatric Infectious Disease Journal2001;20(12):1169‐73. ">Miron 2001</a>). A meta‐analysis of extended interval aminoglycoside dosing (the dose is higher and administered less frequently than in a traditional dosing regime) in children reported that an extended‐dose aminoglycoside regimen provided similar or potentially improved efficacy and safety, compared to a 'multiple doses a day' regimen (<a href="./references#CD005091-bbs2-0051" title="Contopoulos‐IoannidisDG , GiotisND , BaliatsaDV , IoannidisJP . Extended‐interval aminoglycoside administration for children: a meta‐analysis. Pediatrics2004;114(1):e111‐8. ">Contopoulos‐Ioannidis 2004</a>). A total of 24 studies in paediatric populations up to 20 years of age, including six studies in neonatal populations, were included in their review. Five neonatal studies used gentamicin and one study used amikacin. </p> <p>Some reports suggest that a 'multiple doses a day' regimen results in subtherapeutic levels and the new practice of extended dosage schedules achieved safe and adequate levels (<a href="./references#CD005091-bbs2-0043" title="BajajM , PalmerK . Gentamicin usage in newborns‐‐a simple and practical regime. Pharmacy World &amp; Science2004;26(4):242‐4. ">Bajaj 2004</a>; <a href="./references#CD005091-bbs2-0055" title="DarmstadtGL , Miller‐BellM , BatraM , LawP , LawK . Extended‐interval dosing of gentamicin for treatment of neonatal sepsis in developed and developing countries. Journal of Health, Population, and Nutrition2008;26:163‐82. ">Darmstadt 2008</a>; <a href="./references#CD005091-bbs2-0046" title="BeggEJ , Vella‐BrincatJW , RobertshaweB , McMurtrieMJ , KirkptrickCM , DarlowB . Eight years' experience of an extended‐interval dosing protocol for gentamicin in neonates. Journal of Antimicrobial Chemotherapy2009;63(5):1043‐9. ">Begg 2009</a>; <a href="./references#CD005091-bbs2-0018" title="HagenI , OymerK . Pharmacological differences between once and twice daily gentamicin dosage in newborns with suspected sepsis. Pharmacy World and Science2009;31(1):18‐23. ">Hagen 2009</a>). It has also been suggested that a dose interval of more than 24 hours is less likely to produce toxic trough levels in  preterm neonates (<a href="./references#CD005091-bbs2-0076" title="LanglassTM , MickleTR . Standard gentamicin dosage regimen in neonates. American Journal of Health‐System Pharmacy1999;56(5):440‐3. ">Langlass 1999</a>; <a href="./references#CD005091-bbs2-0017" title="Gonzalez SantacruzM , Tarazona FarguetaJL , Ferrandis RodriguezO , Tapia ColladosC , Jimenez CoboB . Comparison of two gentamicin dosing schedules in the newborn. Anales de pediatría2008;68(6):581‐8. ">Gonzalez Santacruz M 2008</a>; <a href="./references#CD005091-bbs2-0037" title="ThingvollES , GuilletR , CasertaM , DicenzoR . Observational trial of a 48‐hour gentamicin dosing regimen derived from Monte Carlo simulations in infants born at less than 28 weeks' gestation. Journal of Pediatrics2008;153(4):530‐4. ">Thingvoll 2008</a>). </p> </section> <section id="CD005091-sec-0027"> <h3 class="title" id="CD005091-sec-0027">Why it is important to do this review</h3> <p>Despite this information, the appropriate dose interval for gentamicin in neonates is still a matter of debate. Caution has been expressed against the use of a 'once a day' dose of gentamicin in neonatal infections (<a href="./references#CD005091-bbs2-0048" title="ChambersHF . The aminoglycosides. Goodman and Gillman's The pharmacological basis of therapeutics. McGraw‐Hill Professional, 2001. ">Chambers 2001</a>). This approach has yet to become standard practice in most paediatric hospitals (<a href="./references#CD005091-bbs2-0072" title="KnodererCA , EverettJA , BussWF . Clinical issues surrounding once‐daily aminoglycoside dosing in children. Pharmacotherapy2003;23(1):44‐56. ">Knoderer 2003</a>). A random survey of acute care hospitals in the USA in 1993 found that extended interval aminoglycoside dosing was not practised in neonates, whereas, in 1998, 11.3% of the hospitals were using extended interval dosing (<a href="./references#CD005091-bbs2-0050" title="ChuckSK , RaberSR , RodvoldKA , AreffD . National survey of extended‐interval aminoglycoside dosing. Clinical Infectious Diseases2000;30(3):433‐9. ">Chuck 2000</a>). </p> <p>In this review, we compared 'one dose per day' versus 'multiple doses per day' of gentamicin in neonates with suspected or proven sepsis. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD005091-sec-0028" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD005091-sec-0028"></div> <p>To compare the efficacy and safety of one dose per day to multiple doses per day of gentamicin in suspected or proven sepsis in neonates. </p> <p>Subgroup analysis was performed according to:</p> <p> <ol id="CD005091-list-0002"> <li> <p>gestation: less than 32 weeks and 32 weeks or more;</p> </li> <li> <p>suspected or proven sepsis;</p> </li> <li> <p>intramuscular or intravenous administration;</p> </li> <li> <p>use of loading dose.</p> </li> </ol> </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD005091-sec-0029" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD005091-sec-0029"></div> <section id="CD005091-sec-0030"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD005091-sec-0031"> <h4 class="title">Types of studies</h4> <p>Randomised and quasi‐randomised controlled trials.</p> </section> <section id="CD005091-sec-0032"> <h4 class="title">Types of participants</h4> <p>Newborn infants (≤ 28 days after birth) with suspected or proven sepsis commenced on gentamicin. Suspected sepsis was defined as any condition in the neonate which led to the commencement of antibiotics. Proven sepsis was defined as a clinical condition necessitating use of antibiotics and presence of positive blood/body fluid or tissue cultures. </p> </section> <section id="CD005091-sec-0033"> <h4 class="title">Types of interventions</h4> <p>One dose per day ('once a day') compared to multiple doses per day ('multiple doses a day') of gentamicin. </p> <p>Studies comparing extended dose regimens such as dosing once in 36 to 48 hours versus 'once a day' dosing were not included. </p> <p>Studies comparing regimens with or without loading dosage were not included. If a trial used a loading dose of gentamicin in both groups, it was included. </p> <p>Since gentamicin is almost always used along with a second antibiotic, studies which used the same second antibiotic in both groups were included. </p> <p>Studies using gentamicin either intramuscularly or intravenously were included provided both study and control groups were administered gentamicin by the same route. </p> <p>If a study used a different second antibiotic along with gentamicin in the study and control groups, it was excluded.<br/> A difference of up to 25% while calculating the total daily dose was allowed between 'once a day' and 'multiple doses a day' regimens. </p> </section> <section id="CD005091-sec-0034"> <h4 class="title">Types of outcome measures</h4> <section id="CD005091-sec-0035"> <h5 class="title">Primary outcomes</h5> <p> <ol id="CD005091-list-0003"> <li> <p>Clinical efficacy: clearance of proven sepsis defined as negative blood or other body fluid cultures without the need for a change in antibiotics. </p> </li> <li> <p>Pharmacokinetic efficacy:</p> <ol id="CD005091-list-0004"> <li> <p>Failure to reach adequate peak levels of at least 5 µg/ml. Peak level was defined as the level measured 0.5 to one hour after administration of any dose of gentamicin on any day during the study period. </p> </li> <li> <p>Failure to avoid toxic trough levels of &gt; 2 µg/ml. The trough level was defined as the level measured within one hour prior to the administration of gentamicin on any day during the study period (except the initial dose). </p> </li> </ol> </li> </ol> </p> </section> <section id="CD005091-sec-0036"> <h5 class="title">Secondary outcomes</h5> <p> <ol id="CD005091-list-0005"> <li> <p>Ototoxicity (examination could be performed at the end of the study period or before discharge with or without baseline testing): </p> <ol id="CD005091-list-0006"> <li> <p>Auditory: defined as abnormality in pure tone audiometry or brain‐stem evoked auditory response or otoacoustic emission or any other validated hearing test. </p> </li> <li> <p>Vestibular: defined as abnormality in electronystagmography or any other validated vestibular function test. </p> </li> </ol> </li> <li> <p>Nephrotoxicity (examination could be performed at the end of the study period or before discharge with or without baseline testing): </p> <ol id="CD005091-list-0007"> <li> <p>Primary: any increase in serum creatinine levels or decrease in creatinine clearance, with thresholds as defined in each study. </p> </li> <li> <p>Secondary: urinary excretion of proteins (retinal binding protein, beta‐2 microglobulin, Clara cell protein, microalbumin, N‐Acetyl‐Beta‐D‐glucosaminidase, alkaline phosphatase, alanine aminopeptidase, or gamma‐glutamyl transferase, cystatin C) or phospholipids. </p> </li> </ol> </li> <li> <p>Treatment failure: persistent positive blood/body fluid or tissue cultures which lead to any modification of the assigned antibiotic dosing or addition of new antibiotic. </p> </li> <li> <p>Actual peak levels (mean and SD) attained (µg/ml): peak levels were defined as levels measured at 0.5 to 1 hour after a dose of gentamicin. </p> </li> <li> <p>Actual trough levels (mean and SD) attained (µg/ml): trough levels were defined as levels measured within one hour prior to giving any dose of gentamicin (except the initial dose). </p> </li> </ol> </p> </section> </section> </section> <section id="CD005091-sec-0037"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD005091-sec-0038"> <h4 class="title">Electronic searches</h4> <p>We used the standard search strategy of the Cochrane Neonatal Review Group. This included electronic searches of the Cochrane Central Register of Controlled Trials (CENTRAL; 2016, Issue 3) in the Cochrane Library (searched 8 April 2016), MEDLINE (1966 to 8 April 2016), Embase (1980 to 8 April 2016) and CINAHL (1982 to 8 April 2016) and previous reviews including cross‐references. Abstracts of Pediatric Academic Societies meetings (1995 to 2016) were also searched. MEDLINE and Embase were searched for relevant articles using the following MeSH terms or text words: (Gentamicin/OR aminoglycoside) AND (sepsis OR septicaemia OR septicemia) AND (infant, newborn/OR infant, low birth weight/OR infant, very low birth weight/OR infant, premature/OR Infant, Premature, Diseases) OR (neonate: OR prematur*: OR newborn) AND (clinical trial OR Randomised Controlled Trials). Reference lists of published narrative and systematic reviews were also reviewed. No language restrictions were applied. </p> </section> <section id="CD005091-sec-0039"> <h4 class="title">Searching other resources</h4> <p>We searched clinical trials' registries for ongoing or recently completed trials (<a href="http://clinicaltrials.gov" target="_blank">clinicaltrials.gov</a>; <a href="http://controlled-trials.com" target="_blank">controlled‐trials.com</a>; and <a href="http://who.int/ictrp" target="_blank">who.int/ictrp</a>). We also searched reference lists of identified articles. </p> </section> </section> <section id="CD005091-sec-0040"> <h3 class="title" id="CD005091-sec-0040">Data collection and analysis</h3> <p>We used the standard methods of the Cochrane Neonatal Review Group.</p> <section id="CD005091-sec-0041"> <h4 class="title">Selection of studies</h4> <p>Two review authors independently assessed the eligibility of studies for inclusion.</p> </section> <section id="CD005091-sec-0042"> <h4 class="title">Data extraction and management</h4> <p>We used a data collection form to aid extraction of relevant information and data from each included study. Two review authors extracted the data separately, compared data, and resolved differences by consensus. Any disagreements were resolved by consultation with the third review author. </p> <p>We contacted the authors of all studies to clarify reported data or provide additional data and information including details of methodology. They were sent a standardised table and asked to provide missing data not included in their article if it was available. <a href="./references#CD005091-bbs2-0009" title="SkopnikH , WallrafR , NiesB , TrosterK , HeimannG . Pharmacokinetics and antibacterial activity of daily gentamicin. Archives of Diseases in Childhood1992;67(1 Spec No):57‐61. ">Skopnik 1992</a>, <a href="./references#CD005091-bbs2-0007" title="KrishnanL , GeorgeSA . Gentamicin therapy in preterms: a comparison of two dosage regimens. Indian Pediatrics1997;34(12):1075‐80. ">Krishnan 1997</a>, <a href="./references#CD005091-bbs2-0003" title="deAlba RomeroC , Gomez CastilloE , Manzanares SecadesC , Rodriguez LopezJ , Arreaza LopezL , Saenz ValienteP . Once daily gentamicin dosing in neonates. Pediatric Infectious Disease Journal1998;17(12):1169‐71. ">de Alba Romero 1998</a>, <a href="./references#CD005091-bbs2-0011" title="ThureenPJ , ReiterPD , GresoresA , StolpmanNM , KawatoK , HallDM . Once‐ versus twice‐daily gentamicin dosing in neonates &gt;=34 weeks' gestation: cost‐effectiveness analyses. Pediatrics1999;103(3):594‐8. ">Thureen 1999</a>, <a href="./references#CD005091-bbs2-0002" title="ChotigeatU , NarongsantiA , AyudhyaDP . Gentamicin in neonatal infection: once versus twice daily dosage. Journal of Medical Association of Thailand2001;84(8):1109‐15. ">Chotigeat 2001</a>, <a href="./references#CD005091-bbs2-0004" title="HaganR . Gentamicin in neonates: single vs multiple doses. Abstract book PSANZ 2002. 2002. ">Hagan 2002</a>, <a href="./references#CD005091-bbs2-0008" title="MironD , SteinfeldM , HasaneinJ , FelszerC , ReichD . Tolerability of once‐daily‐dosing of intravenous gentamicin in preterm neonates born at 32‐37 weeks of gestation. Harefuah2003;142(6):413‐5. ">Miron 2003</a> and <a href="./references#CD005091-bbs2-0006" title="KosalaraksaP , JanthepP , JirapraditthaJ , TaksaphanS , KiatchoosakunP . Once versus twice daily dose of gentamicin therapy in Thai neonates. Journal of the Medical Association of Thailand2004;87(4):372‐6. ">Kosalaraksa 2004</a> provided additional information, clarified existing data and also clarified methodology of studies. <a href="./references#CD005091-bbs2-0005" title="HayaniKC , HatzopoulosFK , FrankAL , ThummalaMR , HantschMJ , SchatzBM , et al. Pharmacokinetics of once‐daily dosing of gentamicin in neonates. Journal of Pediatrics1997;131(1 Pt 1):76‐80. ">Hayani 1997</a>, <a href="./references#CD005091-bbs2-0010" title="SolomonR , KuruvillaKA , JobV , SelvakumarR , JeyaseelanL , KanagasabapathyAS , et al. Randomized controlled trial of once vs. twice daily gentamicin therapy in newborn. Indian Pediatrics1999;36(2):133‐7. ">Solomon 1999</a> and <a href="./references#CD005091-bbs2-0001" title="AgarwalG , RastogiA , PyatiS , WilksA , PildesRS . Comparison of once‐daily versus twice‐daily gentamicin dosing regimens in infants &gt; or = 2500 g. Journal of Perinatology2002;22(4):268‐74. ">Agarwal 2002</a> were contacted initially by e‐mail and subsequently by post four weeks later, but did not respond. </p> </section> <section id="CD005091-sec-0043"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>The criteria and standard methods of the Cochrane Neonatal Review Group were used to assess the methodological quality of the included trials. Risk of bias of the included trials was evaluated in terms of adequacy of sequence generation, allocation concealment, blinding of parents or caregivers and assessors to intervention, and completeness of follow‐up in all randomised individuals. This was defined as 'yes', 'no' or 'not clear' for each category. Differences in opinion were resolved after discussion among all three reviewers. See <a href="./appendices#CD005091-sec-0093">Appendix 1</a> for the complete 'Risk of bias' tool. </p> </section> <section id="CD005091-sec-0044"> <h4 class="title">Measures of treatment effect</h4> <p>Statistical analyses were performed using Review Manager software. We analysed categorical data using relative risk (RR), risk difference (RD) and the number needed to treat for an additional beneficial outcome (NNTB). Continuous data were compared using mean difference (MD). We have reported the 95% confidence interval (CI) on all estimates. </p> </section> <section id="CD005091-sec-0045"> <h4 class="title">Unit of analysis issues</h4> <p>If available, we planned to combine results from cluster trials with other trials using generic inverse variance methods. </p> </section> <section id="CD005091-sec-0046"> <h4 class="title">Dealing with missing data</h4> <p>If participant dropout led to missing data then we planned to conduct an intention‐to‐treat analysis. We endeavoured to obtain missing data from the trial authors. </p> </section> <section id="CD005091-sec-0047"> <h4 class="title">Assessment of heterogeneity</h4> <p>Statistical heterogeneity was assessed using the I² statistic. As per the Cochrane guidelines, the I² statistic was interpreted as follows: </p> <p> <ul id="CD005091-list-0008"> <li> <p>0% to 40%: might not be important</p> </li> <li> <p>30% to 60%: may represent moderate heterogeneity</p> </li> <li> <p>50% to 90%: may represent substantial heterogeneity</p> </li> <li> <p>75% to 100%: considerable heterogeneity</p> </li> </ul> </p> </section> <section id="CD005091-sec-0048"> <h4 class="title">Data synthesis</h4> <p>Effect size was expressed as relative risk (RR), risk difference (RD) and 95% confidence intervals (CIs) for categorical data, and mean difference (MD) and 95% CI for continuous data. The fixed‐effect model was used for meta‐analysis. Change scores of auditory and vestibular tests and tests for nephrotoxicity were planned to be meta‐analysed separately from the final value scores. For significant differences NNTB based on 1/RD was calculated. </p> <section id="CD005091-sec-0049"> <h5 class="title">Quality of evidence</h5> <p>We assessed the quality of evidence for the main comparison at the outcome level using the GRADE approach (<a href="./references#CD005091-bbs2-0063" title="GuyattG , OxmanAD , AklEA , KunzR , VistG , BrozekJ , et al. GRADE guidelines: 1. Introduction‐GRADE evidence profiles and summary of findings tables. Journal of Clinical Epidemiology2011;64(4):383‐94. [PUBMED: 21195583] ">Guyatt 2011a</a>). This methodological approach considers evidence from randomised controlled trials as high quality that may be downgraded based on consideration of any of five areas: design (risk of bias), consistency across studies, directness of the evidence, precision of estimates and presence of publication bias (<a href="./references#CD005091-bbs2-0063" title="GuyattG , OxmanAD , AklEA , KunzR , VistG , BrozekJ , et al. GRADE guidelines: 1. Introduction‐GRADE evidence profiles and summary of findings tables. Journal of Clinical Epidemiology2011;64(4):383‐94. [PUBMED: 21195583] ">Guyatt 2011a</a>). The GRADE approach results in an assessment of the quality of a body of evidence in one of four grades: 1) High: We are very confident that the true effect lies close to that of the estimate of the effect; 2) Moderate: We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different; 3) Low: Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect; 4) Very Low: We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect (<a href="./references#CD005091-bbs2-0086" title="SchünemannH , BrożekJ , GuyattG , OxmanA , editors. GRADE Working Group. GRADE handbook for grading quality of evidence and strength of recommendations. Available from www.guidelinedevelopment.org/handbookupdated October 2013. ">Schünemann 2013</a>). </p> <p>The review authors independently assessed the quality of the evidence found for outcomes that were considered as critical for clinical decision making. These outcomes included: clearance of proven sepsis, failure to achieve peak level of at least 5 µg/ml, failure to achieve trough levels of 2 µg/ml or less, ototoxicity and nephrotoxicity. </p> <p>In cases where we considered the risk of bias arising from inadequate concealment of allocation, randomised assignment, complete follow‐up or blinded outcome assessment reduced our confidence in the effect estimates, we downgraded the quality of evidence accordingly (<a href="./references#CD005091-bbs2-0064" title="GuyattGH , OxmanAD , VistG , KunzR , BrozekJ , Alonso‐CoelloP , et al. GRADE guidelines: 4. Rating the quality of evidence‐‐study limitations (risk of bias). Journal of Clinical Epidemiology2011;64(4):407‐15. [PUBMED: 21247734] ">Guyatt 2011b</a>). We evaluated consistency by similarity of point estimates, extent of overlap of confidence intervals and statistical criteria including measurement of heterogeneity (I²). We downgraded the quality of evidence when large and unexplained inconsistency across studies' results was present (i.e. some studies suggest important benefit and others no effect or harm without a clinical explanation) (<a href="./references#CD005091-bbs2-0066" title="GuyattGH , OxmanAD , KunzR , WoodcockJ , BrozekJ , HelfandM , et al. GRADE guidelines: 7. Rating the quality of evidence‐‐inconsistency. Journal of Clinical Epidemiology2011;64(12):1294‐302. [PUBMED: 21803546] ">Guyatt 2011d</a>). Precision was assessed based on the width of the 95% confidence interval (CI) and by calculating the optimal information size (OIS). If the total number of patients included in the pooled effect estimation was less than the number of patients generated by a conventional sample size calculation for a single adequately powered trial, we considered downrating for imprecision (<a href="./references#CD005091-bbs2-0065" title="GuyattGH , OxmanAD , KunzR , BrozekJ , Alonso‐CoelloP , RindD , et al. GRADE guidelines: 6. Rating the quality of evidence‐‐imprecision. Journal of Clinical Epidemiology2011;64(12):1283‐93. [PUBMED: 21839614] ">Guyatt 2011c</a>). When trials were conducted in populations other than the target population, we downgraded the quality of evidence because of indirectness (<a href="./references#CD005091-bbs2-0067" title="GuyattGH , OxmanAD , KunzR , WoodcockJ , BrozekJ , HelfandM , et al. GRADE guidelines: 8. Rating the quality of evidence‐‐indirectness. Journal of Clinical Epidemiology2011;64(12):1303‐10. [PUBMED: 21802903] ">Guyatt 2011e</a>).<br/> <br/> We entered data (i.e. pooled estimates of the effects and corresponding 95% CIs) and explicit judgements for each of the above aspects assessed into the Guideline Development Tool, the software used to create ‘Summary of findings’ tables (<a href="./references#CD005091-bbs2-0062" title="McMaster University. GRADEpro [www.gradepro.org]. McMaster University, 2014. ">GRADEpro</a>). We explained all judgements involving the assessment of the study characteristics described above in footnotes or comments in the ‘Summary of findings’ table. </p> </section> </section> <section id="CD005091-sec-0050"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>Subgroup analysis was performed according to:</p> <p> <ol id="CD005091-list-0009"> <li> <p>gestation: &lt; 32 weeks and ≥ 32 weeks;</p> </li> <li> <p>suspected or proven sepsis;</p> </li> <li> <p>intramuscular or intravenous administration;</p> </li> <li> <p>use of loading dose.</p> </li> </ol> </p> </section> <section id="CD005091-sec-0051"> <h4 class="title">Sensitivity analysis</h4> <p>We planned to conduct sensitivity analyses by excluding studies where trial participants were of extremely low gestation age because these infants may require even further extended dosing intervals for gentamicin (up to 36 to 48 hours). </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD005091-sec-0052" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD005091-sec-0052"></div> <section id="CD005091-sec-0053"> <h3 class="title">Description of studies</h3> <p>For a full description of each trial, see the <a href="./references#CD005091-sec-0103" title="">Characteristics of included studies</a> section. </p> <section id="CD005091-sec-0054"> <h4 class="title">Results of the search</h4> <p>Thirty‐nine studies were identified as potentially eligible. Twenty‐eight were excluded and 11 studies were included in the review; (see <a href="#CD005091-fig-0001">Figure 1</a>). </p> <div class="figure" id="CD005091-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram: review update" data-id="CD005091-fig-0001" src="/cdsr/doi/10.1002/14651858.CD005091.pub4/media/CDSR/CD005091/image_n/nCD005091-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram: review update</p> </div> </div> </div> </section> <section id="CD005091-sec-0055"> <h4 class="title">Included studies</h4> <p>Eleven studies were included in this review. All of them were single centre studies. All of the included studies were undertaken since the early 1990s by investigators attached to perinatal centres in North America, India, Thailand, Germany, Spain and Australia. A total of 574 neonates were enrolled in the 11 included trials. <a href="./references#CD005091-bbs2-0007" title="KrishnanL , GeorgeSA . Gentamicin therapy in preterms: a comparison of two dosage regimens. Indian Pediatrics1997;34(12):1075‐80. ">Krishnan 1997</a>, <a href="./references#CD005091-bbs2-0008" title="MironD , SteinfeldM , HasaneinJ , FelszerC , ReichD . Tolerability of once‐daily‐dosing of intravenous gentamicin in preterm neonates born at 32‐37 weeks of gestation. Harefuah2003;142(6):413‐5. ">Miron 2003</a> and <a href="./references#CD005091-bbs2-0010" title="SolomonR , KuruvillaKA , JobV , SelvakumarR , JeyaseelanL , KanagasabapathyAS , et al. Randomized controlled trial of once vs. twice daily gentamicin therapy in newborn. Indian Pediatrics1999;36(2):133‐7. ">Solomon 1999</a> enrolled infants of more than 32 weeks' gestation. <a href="./references#CD005091-bbs2-0002" title="ChotigeatU , NarongsantiA , AyudhyaDP . Gentamicin in neonatal infection: once versus twice daily dosage. Journal of Medical Association of Thailand2001;84(8):1109‐15. ">Chotigeat 2001</a>, <a href="./references#CD005091-bbs2-0004" title="HaganR . Gentamicin in neonates: single vs multiple doses. Abstract book PSANZ 2002. 2002. ">Hagan 2002</a>, <a href="./references#CD005091-bbs2-0005" title="HayaniKC , HatzopoulosFK , FrankAL , ThummalaMR , HantschMJ , SchatzBM , et al. Pharmacokinetics of once‐daily dosing of gentamicin in neonates. Journal of Pediatrics1997;131(1 Pt 1):76‐80. ">Hayani 1997</a>, <a href="./references#CD005091-bbs2-0006" title="KosalaraksaP , JanthepP , JirapraditthaJ , TaksaphanS , KiatchoosakunP . Once versus twice daily dose of gentamicin therapy in Thai neonates. Journal of the Medical Association of Thailand2004;87(4):372‐6. ">Kosalaraksa 2004</a> and <a href="./references#CD005091-bbs2-0011" title="ThureenPJ , ReiterPD , GresoresA , StolpmanNM , KawatoK , HallDM . Once‐ versus twice‐daily gentamicin dosing in neonates &gt;=34 weeks' gestation: cost‐effectiveness analyses. Pediatrics1999;103(3):594‐8. ">Thureen 1999</a> enrolled infants whose gestation was 34 weeks or more. <a href="./references#CD005091-bbs2-0001" title="AgarwalG , RastogiA , PyatiS , WilksA , PildesRS . Comparison of once‐daily versus twice‐daily gentamicin dosing regimens in infants &gt; or = 2500 g. Journal of Perinatology2002;22(4):268‐74. ">Agarwal 2002</a> enrolled infants whose birth weight was 2500 g or more; and all except three of the neonates enrolled were above 37 weeks' gestation in this study. <a href="./references#CD005091-bbs2-0009" title="SkopnikH , WallrafR , NiesB , TrosterK , HeimannG . Pharmacokinetics and antibacterial activity of daily gentamicin. Archives of Diseases in Childhood1992;67(1 Spec No):57‐61. ">Skopnik 1992</a> enrolled only full‐term neonates. <a href="./references#CD005091-bbs2-0003" title="deAlba RomeroC , Gomez CastilloE , Manzanares SecadesC , Rodriguez LopezJ , Arreaza LopezL , Saenz ValienteP . Once daily gentamicin dosing in neonates. Pediatric Infectious Disease Journal1998;17(12):1169‐71. ">de Alba Romero 1998</a> enrolled infants whose birth weight was 1200 g or more and was the only study to enrol preterm infants less than 32 weeks' gestational age. </p> <p>All studies used intravenous infusion of gentamicin except <a href="./references#CD005091-bbs2-0007" title="KrishnanL , GeorgeSA . Gentamicin therapy in preterms: a comparison of two dosage regimens. Indian Pediatrics1997;34(12):1075‐80. ">Krishnan 1997</a>, where gentamicin was given as a bolus over one minute. <a href="./references#CD005091-bbs2-0004" title="HaganR . Gentamicin in neonates: single vs multiple doses. Abstract book PSANZ 2002. 2002. ">Hagan 2002</a> and <a href="./references#CD005091-bbs2-0005" title="HayaniKC , HatzopoulosFK , FrankAL , ThummalaMR , HantschMJ , SchatzBM , et al. Pharmacokinetics of once‐daily dosing of gentamicin in neonates. Journal of Pediatrics1997;131(1 Pt 1):76‐80. ">Hayani 1997</a> used gentamicin both intravenously and intramuscularly. Of the 574 infants enrolled in the trial, only 39 infants had proven sepsis (<a href="./references#CD005091-bbs2-0005" title="HayaniKC , HatzopoulosFK , FrankAL , ThummalaMR , HantschMJ , SchatzBM , et al. Pharmacokinetics of once‐daily dosing of gentamicin in neonates. Journal of Pediatrics1997;131(1 Pt 1):76‐80. ">Hayani 1997</a>; <a href="./references#CD005091-bbs2-0003" title="deAlba RomeroC , Gomez CastilloE , Manzanares SecadesC , Rodriguez LopezJ , Arreaza LopezL , Saenz ValienteP . Once daily gentamicin dosing in neonates. Pediatric Infectious Disease Journal1998;17(12):1169‐71. ">de Alba Romero 1998</a>; <a href="./references#CD005091-bbs2-0004" title="HaganR . Gentamicin in neonates: single vs multiple doses. Abstract book PSANZ 2002. 2002. ">Hagan 2002</a>; <a href="./references#CD005091-bbs2-0008" title="MironD , SteinfeldM , HasaneinJ , FelszerC , ReichD . Tolerability of once‐daily‐dosing of intravenous gentamicin in preterm neonates born at 32‐37 weeks of gestation. Harefuah2003;142(6):413‐5. ">Miron 2003</a>; <a href="./references#CD005091-bbs2-0006" title="KosalaraksaP , JanthepP , JirapraditthaJ , TaksaphanS , KiatchoosakunP . Once versus twice daily dose of gentamicin therapy in Thai neonates. Journal of the Medical Association of Thailand2004;87(4):372‐6. ">Kosalaraksa 2004</a>). The rest were treated for suspected sepsis. All studies used gentamicin in the dose of 4 to 5 mg/kg/day either as a single dose or as multiple divided doses. The main outcomes assessed were peak and trough levels of gentamicin and renal function. Three studies assessed hearing prior to discharge (<a href="./references#CD005091-bbs2-0011" title="ThureenPJ , ReiterPD , GresoresA , StolpmanNM , KawatoK , HallDM . Once‐ versus twice‐daily gentamicin dosing in neonates &gt;=34 weeks' gestation: cost‐effectiveness analyses. Pediatrics1999;103(3):594‐8. ">Thureen 1999</a>; <a href="./references#CD005091-bbs2-0001" title="AgarwalG , RastogiA , PyatiS , WilksA , PildesRS . Comparison of once‐daily versus twice‐daily gentamicin dosing regimens in infants &gt; or = 2500 g. Journal of Perinatology2002;22(4):268‐74. ">Agarwal 2002</a>; <a href="./references#CD005091-bbs2-0004" title="HaganR . Gentamicin in neonates: single vs multiple doses. Abstract book PSANZ 2002. 2002. ">Hagan 2002</a>); and one study assessed hearing at one to two months of age (<a href="./references#CD005091-bbs2-0008" title="MironD , SteinfeldM , HasaneinJ , FelszerC , ReichD . Tolerability of once‐daily‐dosing of intravenous gentamicin in preterm neonates born at 32‐37 weeks of gestation. Harefuah2003;142(6):413‐5. ">Miron 2003</a>). One study assessed the cost of therapy (<a href="./references#CD005091-bbs2-0011" title="ThureenPJ , ReiterPD , GresoresA , StolpmanNM , KawatoK , HallDM . Once‐ versus twice‐daily gentamicin dosing in neonates &gt;=34 weeks' gestation: cost‐effectiveness analyses. Pediatrics1999;103(3):594‐8. ">Thureen 1999</a>). The details are described in the table '<a href="./references#CD005091-sec-0103" title="">Characteristics of included studies</a>'. </p> </section> <section id="CD005091-sec-0056"> <h4 class="title">Excluded studies</h4> <p><a href="http://archie.cochrane.org/sections/documents/view?version=05CA337082E26AA201A2F2795EE81913%26format=REVMAN#STD-Skopnik--1995#STD-Skopnik--1995" target="_blank">Skopnik 1995,</a><a href="./references#CD005091-bbs2-0014" title="DaviesMW , CartwrightDW . Gentamicin dosage intervals in neonates: longer dosage interval‐‐less toxicity. Journal of Paediatrics and Child Health1998;34(6):577‐80. ">Davies 1998,</a><a href="./references#CD005091-bbs2-0024" title="KaspersGJ , TeunissenPC , HollH . Gentamicin administration in newborns: once daily. Nederlands Tijdschrift voor Geneeskunde1998;142(11):583‐6. ">Kaspers 1998,</a><a href="./references#CD005091-bbs2-0028" title="LunderganFS , GlasscockGF , KimEH , CohenRS . Once‐daily gentamicin dosing in newborn infants. Pediatrics1999;103(6 Pt 1):1228‐34. ">Lundergan 1999,</a><a href="./references#CD005091-bbs2-0035" title="SticklandMD , KirkpatrickCM , BeggEJ , DuffullSB , OddieSJ , DarlowBA . An extended interval dosing method for gentamicin in neonates. Journal of Antimicrobial Chemotherapy2001;48(6):887‐93. ">Stickland 2001</a>, <a href="http://archie.cochrane.org/sections/documents/view?version=05CA337082E26AA201A2F2795EE81913%26format=REVMAN#STD-Alsaedi--2003#STD-Alsaedi--2003" target="_blank">Alsaedi 2003</a>, <a href="./references#CD005091-bbs2-0019" title="HansenA , ForbesP , ArnoldA , O'RourkeE . Once‐daily gentamicin dosing for the preterm and term newborn: proposal for a simple regimen that achieves target levels. Journal of Perinatology2003;23(8):635‐9. ">Hansen 2003</a>, <a href="./references#CD005091-bbs2-0026" title="LanaoJM , CalvoMV , MesaJA , Martin‐SuarezA , CarbajosaMT , MiguelezF , et al. Pharmacokinetic basis for the use of extended interval dosage regimens of gentamicin in neonates. Journal of Antimicrobial Chemotherapy2004;54(1):193‐8. ">Lanao 2004</a>, <a href="./references#CD005091-bbs2-0036" title="TantiprabhaW , JuntarakanaS , ChotinaruemolS , RojanasthienN . Efficacy and safety of gentamicin by interval and intravenous dosage adjustment based on the gestational age in Thai neonates. Journal of the Medical Association of Thailand2007;90(12):2601‐7. ">Tantiprabha 2007</a>, <a href="./references#CD005091-bbs2-0037" title="ThingvollES , GuilletR , CasertaM , DicenzoR . Observational trial of a 48‐hour gentamicin dosing regimen derived from Monte Carlo simulations in infants born at less than 28 weeks' gestation. Journal of Pediatrics2008;153(4):530‐4. ">Thingvoll 2008</a>, <a href="./references#CD005091-bbs2-0017" title="Gonzalez SantacruzM , Tarazona FarguetaJL , Ferrandis RodriguezO , Tapia ColladosC , Jimenez CoboB . Comparison of two gentamicin dosing schedules in the newborn. Anales de pediatría2008;68(6):581‐8. ">Gonzalez Santacruz M 2008</a>, <a href="./references#CD005091-bbs2-0033" title="SeraneTV , ZengeyaS , PenfordG , CookeJ , KhannaG , McGregor‐ColmanE . Once daily dose gentamicin in neonates ‒ is our dosing correct?. Acta Paediatrica2009;98(7):1100‐5. ">Serane 2009</a> and <a href="./references#CD005091-bbs2-0018" title="HagenI , OymerK . Pharmacological differences between once and twice daily gentamicin dosage in newborns with suspected sepsis. Pharmacy World and Science2009;31(1):18‐23. ">Hagen 2009</a> were excluded because they were not randomised or quasi‐randomised controlled trials. <a href="./references#CD005091-bbs2-0015" title="EnglishM , MohammedS , RossA , NdiranguS , KokwaroG , ShannF , et al. A randomised, controlled trial of once daily and multi‐dose daily gentamicin in young Kenyan infants. Archives Of Disease in Childhood2004;89(7):665‐9. ">English 2004</a> was excluded because a loading dose of 8 mg/kg was used in the 'once a day' gentamicin regimen, whereas no loading dose was used in the 'multiple doses a day' regimen. <a href="./references#CD005091-bbs2-0030" title="MercadoMC , BrodskyNL , McGuireMK , HurtH . Extended interval dosing of gentamicin in preterm infants. American Journal of Perinatology2004;21(2):73‐7. ">Mercado 2004</a> and <a href="http://archie.cochrane.org/sections/documents/view?version=05CA337082E26AA201A2F2795EE81913%26format=REVMAN#STD-Rastogi--2002#STD-Rastogi--2002" target="_blank">Rastogi 2002</a> were excluded because they compared a 'once a day' to a 'once in 48 hours' regimen of gentamicin. <a href="./references#CD005091-bbs2-0023" title="IsemannBT , KotagalUR , MashniSM , LuckhauptEJ , JohnsonCJ . Optimal gentamicin therapy in preterm neonates includes loading doses and early monitoring. Therapeutic Drug Monitoring1996;18(5):549‐55. ">Isemann 1996</a> and <a href="./references#CD005091-bbs2-0032" title="SemchukW , ShevchukYM , SankaranK , WallaceSM . Prospective, randomized, controlled evaluation of a gentamicin loading dose in neonates. Biology of the Neonate1995;67(1):13‐20. ">Semchuk 1995</a> were excluded because the regimen of loading dose was compared to the regimen of no loading dose of gentamicin. <a href="./references#CD005091-bbs2-0038" title="TiwariS , RehanHS , ChandraJ , MathurNN , SinghV . Efficacy and safety of a single daily dose of gentamicin in hospitalized Indian children: a quasi‐randomized trial. Journal of Antimicrobial Chemotherapy2009;64(5):1096‐101. ">Tiwari 2009</a> was excluded because relevant data from the neonatal subgroup could not be obtained from the published article. We made three attempts to contact the authors but there was no response. </p> <p><a href="./references#CD005091-bbs2-0039" title="YeungMY , SmythJP . Targeting gentamicin concentrations in babies: the younger the baby, the larger the loading dose and the longer the dose interval. Australian Journal of Hospital Pharmacy2000;30(3):98‐101. ">Yeung 2000</a>, <a href="./references#CD005091-bbs2-0020" title="HiltronAE , SunY , ScarpaceSB . Accuracy of empiric gentamicin dosing guidelines in neonates. The Journal of Pediatric Pharmacology and Therapeutics2010;15(4):264‐73. [PUBMED: 22477814] ">Hiltron 2010</a>, <a href="./references#CD005091-bbs2-0022" title="HossainMM , ChowdhuryNA , ShirinMS , SahaSK , Miller‐BellM , EdwardsD , et al. Simplified dosing of gentamicin for treatment of sepsis in Bangladeshi neonates. Journal of Health, Population and Nutrition2009;27(5):640‐5. [PUBMED: 19902799] ">Hossain 2009</a>, <a href="./references#CD005091-bbs2-0029" title="MartinkovaJ , PokornaP , ZahoraJ , ChladekJ , VobrubaV , Selke‐KrulichovaI , et al. Tolerability and outcomes of kinetically guided therapy with gentamicin in critically ill neonates during the first week of life: An open‐label, prospective study. Clinical Therapeutics2010;32(14):2400‐14. [PUBMED: 21353108] ">Martinkova 2010</a>, <a href="./references#CD005091-bbs2-0013" title="AlshaikhB , Dersch‐MillsD , TaylorR , AkiermanAR , YusufK . Extended interval dosing of gentamicin in premature neonates ≤ 2‐week gestation. Acta Paediatrica2012;101(11):1134‐9. [PUBMED: 22897142] ">Alshaikh 2012</a>, <a href="./references#CD005091-bbs2-0016" title="FjalstadJW , LaukliE , van denAnkerJN , KlingenbergC . High‐dose gentamicin in newborn infant: is it safe?. European Journal of Paediatrics2014;173(4):489‐95. [PUBMED: 10717501] ">Fjalstad 2014</a>, <a href="./references#CD005091-bbs2-0021" title="HoffDS , WilcoxRA , TollefsonLM , LipnikPG , CommersAR , LiuM . Pharmacokinetic outcomes of a simplified, weight‐based, extended‐interval gentamicin dosing protocol in critically ill neonates. Pharmacotherapy2009;29(11):1297‐305. [PUBMED: 19857147] ">Hoff 2009</a>, <a href="./references#CD005091-bbs2-0025" title="KrishnamoorthySS , NairA , FurnessJ , SandersonJ . Gentamicin use in neonates: should we have a change of practice?. Scottish Medical Journal2013;58(4):241‐5. [PUBMED: 24215045] ">Krishnamoorthy 2013</a> and <a href="./references#CD005091-bbs2-0027" title="LowYS , TanSL , WanAS . Extended‐interval gentamicin dosing in achieving therapeutic concentrations in Malaysian neonates. Journal of Pediatric Pharmacology and Therapeutics2015;20(2):119‐25. [PUBMED: 25964729] ">Low 2015</a> were also excluded because they were observational studies comparing 'once a day' dosing to different extended dosing regimens. </p> <p>The details are listed in the table '<a href="./references#CD005091-sec-0104" title="">Characteristics of excluded studies</a>'. </p> </section> </section> <section id="CD005091-sec-0057"> <h3 class="title">Risk of bias in included studies</h3> <p>The details of risk of bias are described in <a href="#CD005091-fig-0002">Figure 2</a>. </p> <div class="figure" id="CD005091-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD005091-fig-0002" src="/cdsr/doi/10.1002/14651858.CD005091.pub4/media/CDSR/CD005091/image_n/nCD005091-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <p>Details of the methodological quality of studies are included under the table '<a href="./references#CD005091-sec-0103" title="">Characteristics of included studies</a>'. </p> <section id="CD005091-sec-0058"> <h4 class="title">Allocation</h4> <p><b>Adequacy of sequence generation</b> was accomplished using computer‐generated random numbers in <a href="./references#CD005091-bbs2-0009" title="SkopnikH , WallrafR , NiesB , TrosterK , HeimannG . Pharmacokinetics and antibacterial activity of daily gentamicin. Archives of Diseases in Childhood1992;67(1 Spec No):57‐61. ">Skopnik 1992</a>, <a href="./references#CD005091-bbs2-0007" title="KrishnanL , GeorgeSA . Gentamicin therapy in preterms: a comparison of two dosage regimens. Indian Pediatrics1997;34(12):1075‐80. ">Krishnan 1997</a>, <a href="./references#CD005091-bbs2-0001" title="AgarwalG , RastogiA , PyatiS , WilksA , PildesRS . Comparison of once‐daily versus twice‐daily gentamicin dosing regimens in infants &gt; or = 2500 g. Journal of Perinatology2002;22(4):268‐74. ">Agarwal 2002</a>, <a href="./references#CD005091-bbs2-0004" title="HaganR . Gentamicin in neonates: single vs multiple doses. Abstract book PSANZ 2002. 2002. ">Hagan 2002</a> and <a href="./references#CD005091-bbs2-0006" title="KosalaraksaP , JanthepP , JirapraditthaJ , TaksaphanS , KiatchoosakunP . Once versus twice daily dose of gentamicin therapy in Thai neonates. Journal of the Medical Association of Thailand2004;87(4):372‐6. ">Kosalaraksa 2004</a>. </p> <p><b>Allocation concealment:</b> <br/> Allocation concealment was accomplished in <a href="./references#CD005091-bbs2-0007" title="KrishnanL , GeorgeSA . Gentamicin therapy in preterms: a comparison of two dosage regimens. Indian Pediatrics1997;34(12):1075‐80. ">Krishnan 1997</a>, <a href="./references#CD005091-bbs2-0003" title="deAlba RomeroC , Gomez CastilloE , Manzanares SecadesC , Rodriguez LopezJ , Arreaza LopezL , Saenz ValienteP . Once daily gentamicin dosing in neonates. Pediatric Infectious Disease Journal1998;17(12):1169‐71. ">de Alba Romero 1998</a>, <a href="./references#CD005091-bbs2-0002" title="ChotigeatU , NarongsantiA , AyudhyaDP . Gentamicin in neonatal infection: once versus twice daily dosage. Journal of Medical Association of Thailand2001;84(8):1109‐15. ">Chotigeat 2001</a>, <a href="./references#CD005091-bbs2-0001" title="AgarwalG , RastogiA , PyatiS , WilksA , PildesRS . Comparison of once‐daily versus twice‐daily gentamicin dosing regimens in infants &gt; or = 2500 g. Journal of Perinatology2002;22(4):268‐74. ">Agarwal 2002</a>, <a href="./references#CD005091-bbs2-0004" title="HaganR . Gentamicin in neonates: single vs multiple doses. Abstract book PSANZ 2002. 2002. ">Hagan 2002</a> and <a href="./references#CD005091-bbs2-0006" title="KosalaraksaP , JanthepP , JirapraditthaJ , TaksaphanS , KiatchoosakunP . Once versus twice daily dose of gentamicin therapy in Thai neonates. Journal of the Medical Association of Thailand2004;87(4):372‐6. ">Kosalaraksa 2004</a> using sealed envelopes. It was not clear if allocation was concealed in <a href="./references#CD005091-bbs2-0010" title="SolomonR , KuruvillaKA , JobV , SelvakumarR , JeyaseelanL , KanagasabapathyAS , et al. Randomized controlled trial of once vs. twice daily gentamicin therapy in newborn. Indian Pediatrics1999;36(2):133‐7. ">Solomon 1999</a>, <a href="./references#CD005091-bbs2-0009" title="SkopnikH , WallrafR , NiesB , TrosterK , HeimannG . Pharmacokinetics and antibacterial activity of daily gentamicin. Archives of Diseases in Childhood1992;67(1 Spec No):57‐61. ">Skopnik 1992</a> and <a href="./references#CD005091-bbs2-0005" title="HayaniKC , HatzopoulosFK , FrankAL , ThummalaMR , HantschMJ , SchatzBM , et al. Pharmacokinetics of once‐daily dosing of gentamicin in neonates. Journal of Pediatrics1997;131(1 Pt 1):76‐80. ">Hayani 1997</a>. Allocation was not concealed in <a href="./references#CD005091-bbs2-0008" title="MironD , SteinfeldM , HasaneinJ , FelszerC , ReichD . Tolerability of once‐daily‐dosing of intravenous gentamicin in preterm neonates born at 32‐37 weeks of gestation. Harefuah2003;142(6):413‐5. ">Miron 2003</a> and <a href="./references#CD005091-bbs2-0011" title="ThureenPJ , ReiterPD , GresoresA , StolpmanNM , KawatoK , HallDM . Once‐ versus twice‐daily gentamicin dosing in neonates &gt;=34 weeks' gestation: cost‐effectiveness analyses. Pediatrics1999;103(3):594‐8. ">Thureen 1999</a>. <a href="./references#CD005091-bbs2-0008" title="MironD , SteinfeldM , HasaneinJ , FelszerC , ReichD . Tolerability of once‐daily‐dosing of intravenous gentamicin in preterm neonates born at 32‐37 weeks of gestation. Harefuah2003;142(6):413‐5. ">Miron 2003</a> was a quasi‐random study with 'once a day' gentamicin being administered in period one (January to March 1998) and 'multiple doses a day' gentamicin being administered in period two (April to June 1998). <a href="./references#CD005091-bbs2-0011" title="ThureenPJ , ReiterPD , GresoresA , StolpmanNM , KawatoK , HallDM . Once‐ versus twice‐daily gentamicin dosing in neonates &gt;=34 weeks' gestation: cost‐effectiveness analyses. Pediatrics1999;103(3):594‐8. ">Thureen 1999</a> was also a quasi‐random study (assignment to a particular study group was dependent on the intensive care site, with monthly rotation of dosing regimens). </p> </section> <section id="CD005091-sec-0059"> <h4 class="title">Blinding</h4> <p><b>Blinding of intervention:</b> <br/> Blinding of intervention was not done in any of the studies.<br/> <br/> <b>Blinding of outcome assessment:</b> <br/> Outcome assessment was blinded in <a href="./references#CD005091-bbs2-0007" title="KrishnanL , GeorgeSA . Gentamicin therapy in preterms: a comparison of two dosage regimens. Indian Pediatrics1997;34(12):1075‐80. ">Krishnan 1997</a>, <a href="./references#CD005091-bbs2-0003" title="deAlba RomeroC , Gomez CastilloE , Manzanares SecadesC , Rodriguez LopezJ , Arreaza LopezL , Saenz ValienteP . Once daily gentamicin dosing in neonates. Pediatric Infectious Disease Journal1998;17(12):1169‐71. ">de Alba Romero 1998</a>, <a href="./references#CD005091-bbs2-0002" title="ChotigeatU , NarongsantiA , AyudhyaDP . Gentamicin in neonatal infection: once versus twice daily dosage. Journal of Medical Association of Thailand2001;84(8):1109‐15. ">Chotigeat 2001</a>, <a href="./references#CD005091-bbs2-0004" title="HaganR . Gentamicin in neonates: single vs multiple doses. Abstract book PSANZ 2002. 2002. ">Hagan 2002</a>, <a href="./references#CD005091-bbs2-0008" title="MironD , SteinfeldM , HasaneinJ , FelszerC , ReichD . Tolerability of once‐daily‐dosing of intravenous gentamicin in preterm neonates born at 32‐37 weeks of gestation. Harefuah2003;142(6):413‐5. ">Miron 2003</a> and <a href="./references#CD005091-bbs2-0006" title="KosalaraksaP , JanthepP , JirapraditthaJ , TaksaphanS , KiatchoosakunP . Once versus twice daily dose of gentamicin therapy in Thai neonates. Journal of the Medical Association of Thailand2004;87(4):372‐6. ">Kosalaraksa 2004</a>. It was not clear whether outcome assessment was blinded in <a href="./references#CD005091-bbs2-0005" title="HayaniKC , HatzopoulosFK , FrankAL , ThummalaMR , HantschMJ , SchatzBM , et al. Pharmacokinetics of once‐daily dosing of gentamicin in neonates. Journal of Pediatrics1997;131(1 Pt 1):76‐80. ">Hayani 1997</a>, <a href="./references#CD005091-bbs2-0010" title="SolomonR , KuruvillaKA , JobV , SelvakumarR , JeyaseelanL , KanagasabapathyAS , et al. Randomized controlled trial of once vs. twice daily gentamicin therapy in newborn. Indian Pediatrics1999;36(2):133‐7. ">Solomon 1999</a> and <a href="./references#CD005091-bbs2-0001" title="AgarwalG , RastogiA , PyatiS , WilksA , PildesRS . Comparison of once‐daily versus twice‐daily gentamicin dosing regimens in infants &gt; or = 2500 g. Journal of Perinatology2002;22(4):268‐74. ">Agarwal 2002</a>. It was not blinded in <a href="./references#CD005091-bbs2-0009" title="SkopnikH , WallrafR , NiesB , TrosterK , HeimannG . Pharmacokinetics and antibacterial activity of daily gentamicin. Archives of Diseases in Childhood1992;67(1 Spec No):57‐61. ">Skopnik 1992</a> and <a href="./references#CD005091-bbs2-0011" title="ThureenPJ , ReiterPD , GresoresA , StolpmanNM , KawatoK , HallDM . Once‐ versus twice‐daily gentamicin dosing in neonates &gt;=34 weeks' gestation: cost‐effectiveness analyses. Pediatrics1999;103(3):594‐8. ">Thureen 1999</a>. </p> </section> <section id="CD005091-sec-0060"> <h4 class="title">Incomplete outcome data</h4> <p><a href="./references#CD005091-bbs2-0009" title="SkopnikH , WallrafR , NiesB , TrosterK , HeimannG . Pharmacokinetics and antibacterial activity of daily gentamicin. Archives of Diseases in Childhood1992;67(1 Spec No):57‐61. ">Skopnik 1992</a>, <a href="./references#CD005091-bbs2-0007" title="KrishnanL , GeorgeSA . Gentamicin therapy in preterms: a comparison of two dosage regimens. Indian Pediatrics1997;34(12):1075‐80. ">Krishnan 1997</a>, <a href="./references#CD005091-bbs2-0010" title="SolomonR , KuruvillaKA , JobV , SelvakumarR , JeyaseelanL , KanagasabapathyAS , et al. Randomized controlled trial of once vs. twice daily gentamicin therapy in newborn. Indian Pediatrics1999;36(2):133‐7. ">Solomon 1999</a>, <a href="./references#CD005091-bbs2-0011" title="ThureenPJ , ReiterPD , GresoresA , StolpmanNM , KawatoK , HallDM . Once‐ versus twice‐daily gentamicin dosing in neonates &gt;=34 weeks' gestation: cost‐effectiveness analyses. Pediatrics1999;103(3):594‐8. ">Thureen 1999</a>, <a href="./references#CD005091-bbs2-0002" title="ChotigeatU , NarongsantiA , AyudhyaDP . Gentamicin in neonatal infection: once versus twice daily dosage. Journal of Medical Association of Thailand2001;84(8):1109‐15. ">Chotigeat 2001</a>, <a href="./references#CD005091-bbs2-0001" title="AgarwalG , RastogiA , PyatiS , WilksA , PildesRS . Comparison of once‐daily versus twice‐daily gentamicin dosing regimens in infants &gt; or = 2500 g. Journal of Perinatology2002;22(4):268‐74. ">Agarwal 2002</a>, <a href="./references#CD005091-bbs2-0008" title="MironD , SteinfeldM , HasaneinJ , FelszerC , ReichD . Tolerability of once‐daily‐dosing of intravenous gentamicin in preterm neonates born at 32‐37 weeks of gestation. Harefuah2003;142(6):413‐5. ">Miron 2003</a> and <a href="./references#CD005091-bbs2-0006" title="KosalaraksaP , JanthepP , JirapraditthaJ , TaksaphanS , KiatchoosakunP . Once versus twice daily dose of gentamicin therapy in Thai neonates. Journal of the Medical Association of Thailand2004;87(4):372‐6. ">Kosalaraksa 2004</a> reported complete follow‐up. Follow‐up was incomplete in the <a href="./references#CD005091-bbs2-0005" title="HayaniKC , HatzopoulosFK , FrankAL , ThummalaMR , HantschMJ , SchatzBM , et al. Pharmacokinetics of once‐daily dosing of gentamicin in neonates. Journal of Pediatrics1997;131(1 Pt 1):76‐80. ">Hayani 1997</a>, <a href="./references#CD005091-bbs2-0004" title="HaganR . Gentamicin in neonates: single vs multiple doses. Abstract book PSANZ 2002. 2002. ">Hagan 2002</a> and <a href="./references#CD005091-bbs2-0003" title="deAlba RomeroC , Gomez CastilloE , Manzanares SecadesC , Rodriguez LopezJ , Arreaza LopezL , Saenz ValienteP . Once daily gentamicin dosing in neonates. Pediatric Infectious Disease Journal1998;17(12):1169‐71. ">de Alba Romero 1998</a> trials, in that more than 10% of enrolled infants did not have outcomes assessed. </p> </section> <section id="CD005091-sec-0061"> <h4 class="title">Selective reporting</h4> <p><a href="./references#CD005091-bbs2-0001" title="AgarwalG , RastogiA , PyatiS , WilksA , PildesRS . Comparison of once‐daily versus twice‐daily gentamicin dosing regimens in infants &gt; or = 2500 g. Journal of Perinatology2002;22(4):268‐74. ">Agarwal 2002</a>, <a href="./references#CD005091-bbs2-0002" title="ChotigeatU , NarongsantiA , AyudhyaDP . Gentamicin in neonatal infection: once versus twice daily dosage. Journal of Medical Association of Thailand2001;84(8):1109‐15. ">Chotigeat 2001</a>, <a href="./references#CD005091-bbs2-0004" title="HaganR . Gentamicin in neonates: single vs multiple doses. Abstract book PSANZ 2002. 2002. ">Hagan 2002</a>, <a href="./references#CD005091-bbs2-0005" title="HayaniKC , HatzopoulosFK , FrankAL , ThummalaMR , HantschMJ , SchatzBM , et al. Pharmacokinetics of once‐daily dosing of gentamicin in neonates. Journal of Pediatrics1997;131(1 Pt 1):76‐80. ">Hayani 1997</a>, <a href="./references#CD005091-bbs2-0008" title="MironD , SteinfeldM , HasaneinJ , FelszerC , ReichD . Tolerability of once‐daily‐dosing of intravenous gentamicin in preterm neonates born at 32‐37 weeks of gestation. Harefuah2003;142(6):413‐5. ">Miron 2003</a>, <a href="./references#CD005091-bbs2-0009" title="SkopnikH , WallrafR , NiesB , TrosterK , HeimannG . Pharmacokinetics and antibacterial activity of daily gentamicin. Archives of Diseases in Childhood1992;67(1 Spec No):57‐61. ">Skopnik 1992</a>, <a href="./references#CD005091-bbs2-0010" title="SolomonR , KuruvillaKA , JobV , SelvakumarR , JeyaseelanL , KanagasabapathyAS , et al. Randomized controlled trial of once vs. twice daily gentamicin therapy in newborn. Indian Pediatrics1999;36(2):133‐7. ">Solomon 1999</a> and <a href="./references#CD005091-bbs2-0011" title="ThureenPJ , ReiterPD , GresoresA , StolpmanNM , KawatoK , HallDM . Once‐ versus twice‐daily gentamicin dosing in neonates &gt;=34 weeks' gestation: cost‐effectiveness analyses. Pediatrics1999;103(3):594‐8. ">Thureen 1999</a> reported predetermined outcome measures completely. In <a href="./references#CD005091-bbs2-0006" title="KosalaraksaP , JanthepP , JirapraditthaJ , TaksaphanS , KiatchoosakunP . Once versus twice daily dose of gentamicin therapy in Thai neonates. Journal of the Medical Association of Thailand2004;87(4):372‐6. ">Kosalaraksa 2004</a>, the statistical method to compare serum creatinine on day 0, 3 and 7 was not pre‐specified. They have not defined measures to evaluate clinical response within 72 hours of treatment. In <a href="./references#CD005091-bbs2-0007" title="KrishnanL , GeorgeSA . Gentamicin therapy in preterms: a comparison of two dosage regimens. Indian Pediatrics1997;34(12):1075‐80. ">Krishnan 1997</a>, there was no pre‐specified analysis method to measure nephrotoxicity but it was reported that there was no nephrotoxicity in either group at the end of therapy. In <a href="./references#CD005091-bbs2-0003" title="deAlba RomeroC , Gomez CastilloE , Manzanares SecadesC , Rodriguez LopezJ , Arreaza LopezL , Saenz ValienteP . Once daily gentamicin dosing in neonates. Pediatric Infectious Disease Journal1998;17(12):1169‐71. ">de Alba Romero 1998</a>, outcome measures to determine clinical efficacy were not described. </p> </section> <section id="CD005091-sec-0062"> <h4 class="title">Other potential sources of bias</h4> <p>All studies appeared to be free of other bias.</p> </section> </section> <section id="CD005091-sec-0063"> <h3 class="title" id="CD005091-sec-0063">Effects of interventions</h3> <p>See: <a href="./full#CD005091-tbl-0001"><b>Summary of findings for the main comparison</b> </a> </p> <p>Eleven studies fulfilled our selection criteria and were included in this review (<a href="./references#CD005091-bbs2-0009" title="SkopnikH , WallrafR , NiesB , TrosterK , HeimannG . Pharmacokinetics and antibacterial activity of daily gentamicin. Archives of Diseases in Childhood1992;67(1 Spec No):57‐61. ">Skopnik 1992</a>; <a href="./references#CD005091-bbs2-0007" title="KrishnanL , GeorgeSA . Gentamicin therapy in preterms: a comparison of two dosage regimens. Indian Pediatrics1997;34(12):1075‐80. ">Krishnan 1997</a>; <a href="./references#CD005091-bbs2-0005" title="HayaniKC , HatzopoulosFK , FrankAL , ThummalaMR , HantschMJ , SchatzBM , et al. Pharmacokinetics of once‐daily dosing of gentamicin in neonates. Journal of Pediatrics1997;131(1 Pt 1):76‐80. ">Hayani 1997</a>; <a href="./references#CD005091-bbs2-0003" title="deAlba RomeroC , Gomez CastilloE , Manzanares SecadesC , Rodriguez LopezJ , Arreaza LopezL , Saenz ValienteP . Once daily gentamicin dosing in neonates. Pediatric Infectious Disease Journal1998;17(12):1169‐71. ">de Alba Romero 1998</a>; <a href="./references#CD005091-bbs2-0010" title="SolomonR , KuruvillaKA , JobV , SelvakumarR , JeyaseelanL , KanagasabapathyAS , et al. Randomized controlled trial of once vs. twice daily gentamicin therapy in newborn. Indian Pediatrics1999;36(2):133‐7. ">Solomon 1999</a>; <a href="./references#CD005091-bbs2-0011" title="ThureenPJ , ReiterPD , GresoresA , StolpmanNM , KawatoK , HallDM . Once‐ versus twice‐daily gentamicin dosing in neonates &gt;=34 weeks' gestation: cost‐effectiveness analyses. Pediatrics1999;103(3):594‐8. ">Thureen 1999</a>; <a href="./references#CD005091-bbs2-0002" title="ChotigeatU , NarongsantiA , AyudhyaDP . Gentamicin in neonatal infection: once versus twice daily dosage. Journal of Medical Association of Thailand2001;84(8):1109‐15. ">Chotigeat 2001</a>; <a href="./references#CD005091-bbs2-0001" title="AgarwalG , RastogiA , PyatiS , WilksA , PildesRS . Comparison of once‐daily versus twice‐daily gentamicin dosing regimens in infants &gt; or = 2500 g. Journal of Perinatology2002;22(4):268‐74. ">Agarwal 2002</a>; <a href="./references#CD005091-bbs2-0004" title="HaganR . Gentamicin in neonates: single vs multiple doses. Abstract book PSANZ 2002. 2002. ">Hagan 2002</a>; <a href="./references#CD005091-bbs2-0008" title="MironD , SteinfeldM , HasaneinJ , FelszerC , ReichD . Tolerability of once‐daily‐dosing of intravenous gentamicin in preterm neonates born at 32‐37 weeks of gestation. Harefuah2003;142(6):413‐5. ">Miron 2003</a>; <a href="./references#CD005091-bbs2-0006" title="KosalaraksaP , JanthepP , JirapraditthaJ , TaksaphanS , KiatchoosakunP . Once versus twice daily dose of gentamicin therapy in Thai neonates. Journal of the Medical Association of Thailand2004;87(4):372‐6. ">Kosalaraksa 2004</a>). These studies included a total of 574 infants. There was no disagreement regarding inclusion/exclusion of studies, quality assessment or data extraction. Available data were pooled and analysed as listed below. </p> <section id="CD005091-sec-0064"> <h4 class="title">Primary outcome measures</h4> <section id="CD005091-sec-0065"> <h5 class="title">Clinical efficacy:</h5> <section id="CD005091-sec-0066"> <h6 class="title">All studies comparing 'once a day' versus 'multiple doses a day' regimen (Comparison 1) </h6> </section> <section id="CD005091-sec-0067"> <h6 class="title">Clearance of proven sepsis (Outcome 1.1)</h6> <p>Clearance of proven sepsis was defined as negative blood or other body fluid cultures without the need for changing antibiotic (<a href="#CD005091-fig-0003">Figure 3</a>). In the <a href="./references#CD005091-bbs2-0003" title="deAlba RomeroC , Gomez CastilloE , Manzanares SecadesC , Rodriguez LopezJ , Arreaza LopezL , Saenz ValienteP . Once daily gentamicin dosing in neonates. Pediatric Infectious Disease Journal1998;17(12):1169‐71. ">de Alba Romero 1998</a> study, both 'once a day' and 'multiple doses a day' regimens achieved clearance of sepsis in all the 29 neonates with proven sepsis. There were two Gram‐positive bacterial infections in the <a href="./references#CD005091-bbs2-0006" title="KosalaraksaP , JanthepP , JirapraditthaJ , TaksaphanS , KiatchoosakunP . Once versus twice daily dose of gentamicin therapy in Thai neonates. Journal of the Medical Association of Thailand2004;87(4):372‐6. ">Kosalaraksa 2004</a> trial: we excluded them from analysis. Only one infant had proven sepsis in the study by <a href="./references#CD005091-bbs2-0005" title="HayaniKC , HatzopoulosFK , FrankAL , ThummalaMR , HantschMJ , SchatzBM , et al. Pharmacokinetics of once‐daily dosing of gentamicin in neonates. Journal of Pediatrics1997;131(1 Pt 1):76‐80. ">Hayani 1997</a>; its outcome was not reported. <a href="./references#CD005091-bbs2-0004" title="HaganR . Gentamicin in neonates: single vs multiple doses. Abstract book PSANZ 2002. 2002. ">Hagan 2002</a> reported that all five infants with proven bacteriological sepsis in the 'once a day' gentamicin group responded by clearance of sepsis; and there were no cases of proven sepsis in the 'multiple doses a day' gentamicin group. <a href="./references#CD005091-bbs2-0008" title="MironD , SteinfeldM , HasaneinJ , FelszerC , ReichD . Tolerability of once‐daily‐dosing of intravenous gentamicin in preterm neonates born at 32‐37 weeks of gestation. Harefuah2003;142(6):413‐5. ">Miron 2003</a> had one infant in each group with proven sepsis; both infants had clearance of sepsis after institution of antibiotic therapy. Meta‐analysis of all studies did not show significant difference between the two groups (typical RR 1.00, 95% CI 0.84 to 1.19; typical RD 0.00, 95% CI −0.19 to 0.19; 3 trials; N = 37). </p> <div class="figure" id="CD005091-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 1 All studies comparing 'once a day' versus 'multiple doses a day' regimen, outcome: 1.1 Clearance of proven sepsis." data-id="CD005091-fig-0003" src="/cdsr/doi/10.1002/14651858.CD005091.pub4/media/CDSR/CD005091/image_n/nCD005091-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 1 All studies comparing 'once a day' versus 'multiple doses a day' regimen, outcome: 1.1 Clearance of proven sepsis. </p> </div> </div> </div> </section> </section> <section id="CD005091-sec-0068"> <h5 class="title">Pharmacokinetic efficacy:</h5> <section id="CD005091-sec-0069"> <h6 class="title">Failure to attain peak levels of at least 5 µg/ml (Outcome 1.2)</h6> <p>Peak levels of at least 5 µg/ml were considered to be essential to declare that a particular dosing regimen was pharmacologically effective (<a href="#CD005091-fig-0004">Figure 4</a>). <a href="./references#CD005091-bbs2-0009" title="SkopnikH , WallrafR , NiesB , TrosterK , HeimannG . Pharmacokinetics and antibacterial activity of daily gentamicin. Archives of Diseases in Childhood1992;67(1 Spec No):57‐61. ">Skopnik 1992</a>, <a href="./references#CD005091-bbs2-0005" title="HayaniKC , HatzopoulosFK , FrankAL , ThummalaMR , HantschMJ , SchatzBM , et al. Pharmacokinetics of once‐daily dosing of gentamicin in neonates. Journal of Pediatrics1997;131(1 Pt 1):76‐80. ">Hayani 1997</a>, <a href="./references#CD005091-bbs2-0003" title="deAlba RomeroC , Gomez CastilloE , Manzanares SecadesC , Rodriguez LopezJ , Arreaza LopezL , Saenz ValienteP . Once daily gentamicin dosing in neonates. Pediatric Infectious Disease Journal1998;17(12):1169‐71. ">de Alba Romero 1998</a>, <a href="./references#CD005091-bbs2-0011" title="ThureenPJ , ReiterPD , GresoresA , StolpmanNM , KawatoK , HallDM . Once‐ versus twice‐daily gentamicin dosing in neonates &gt;=34 weeks' gestation: cost‐effectiveness analyses. Pediatrics1999;103(3):594‐8. ">Thureen 1999</a>, <a href="./references#CD005091-bbs2-0002" title="ChotigeatU , NarongsantiA , AyudhyaDP . Gentamicin in neonatal infection: once versus twice daily dosage. Journal of Medical Association of Thailand2001;84(8):1109‐15. ">Chotigeat 2001</a>, <a href="./references#CD005091-bbs2-0001" title="AgarwalG , RastogiA , PyatiS , WilksA , PildesRS . Comparison of once‐daily versus twice‐daily gentamicin dosing regimens in infants &gt; or = 2500 g. Journal of Perinatology2002;22(4):268‐74. ">Agarwal 2002</a>, <a href="./references#CD005091-bbs2-0004" title="HaganR . Gentamicin in neonates: single vs multiple doses. Abstract book PSANZ 2002. 2002. ">Hagan 2002</a>, <a href="./references#CD005091-bbs2-0008" title="MironD , SteinfeldM , HasaneinJ , FelszerC , ReichD . Tolerability of once‐daily‐dosing of intravenous gentamicin in preterm neonates born at 32‐37 weeks of gestation. Harefuah2003;142(6):413‐5. ">Miron 2003</a> and <a href="./references#CD005091-bbs2-0006" title="KosalaraksaP , JanthepP , JirapraditthaJ , TaksaphanS , KiatchoosakunP . Once versus twice daily dose of gentamicin therapy in Thai neonates. Journal of the Medical Association of Thailand2004;87(4):372‐6. ">Kosalaraksa 2004</a> reported this outcome. Only <a href="./references#CD005091-bbs2-0008" title="MironD , SteinfeldM , HasaneinJ , FelszerC , ReichD . Tolerability of once‐daily‐dosing of intravenous gentamicin in preterm neonates born at 32‐37 weeks of gestation. Harefuah2003;142(6):413‐5. ">Miron 2003</a> reported a statistically significant difference that favoured 'once a day' gentamicin compared to 'multiple doses a day' gentamicin. However, meta‐analysis of all the studies showed a statistically significant difference indicating that a 'once a day' regimen is associated with less failures than a 'multiple doses a day' regimen (typical RR 0.22, 95% CI 0.11 to 0.47; typical RD −0.13, 95% CI −0.19 to −0.08; number needed to treat for an additional beneficial outcome (NNTB) = 8; 9 trials; N = 422). </p> <div class="figure" id="CD005091-fig-0004"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 4</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 1 All studies comparing 'once a day' versus 'multiple doses a day' regimen, outcome: 1.2 Failure to achieve peak levels of at least 5 microgram/ml." data-id="CD005091-fig-0004" src="/cdsr/doi/10.1002/14651858.CD005091.pub4/media/CDSR/CD005091/image_n/nCD005091-AFig-FIG04.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 1 All studies comparing 'once a day' versus 'multiple doses a day' regimen, outcome: 1.2 Failure to achieve peak levels of at least 5 microgram/ml. </p> </div> </div> </div> </section> <section id="CD005091-sec-0070"> <h6 class="title">Failure to achieve trough levels of ≤ 2 µg/ml (Outcome 1.3)</h6> <p>Trough levels of 2 µg/ml or less were considered to be essential to declare that a particular dosing regimen was pharmacologically safe (<a href="#CD005091-fig-0005">Figure 5</a>). All studies reported this outcome measure. <a href="./references#CD005091-bbs2-0007" title="KrishnanL , GeorgeSA . Gentamicin therapy in preterms: a comparison of two dosage regimens. Indian Pediatrics1997;34(12):1075‐80. ">Krishnan 1997</a>, <a href="./references#CD005091-bbs2-0011" title="ThureenPJ , ReiterPD , GresoresA , StolpmanNM , KawatoK , HallDM . Once‐ versus twice‐daily gentamicin dosing in neonates &gt;=34 weeks' gestation: cost‐effectiveness analyses. Pediatrics1999;103(3):594‐8. ">Thureen 1999</a>, <a href="./references#CD005091-bbs2-0008" title="MironD , SteinfeldM , HasaneinJ , FelszerC , ReichD . Tolerability of once‐daily‐dosing of intravenous gentamicin in preterm neonates born at 32‐37 weeks of gestation. Harefuah2003;142(6):413‐5. ">Miron 2003</a> and <a href="./references#CD005091-bbs2-0006" title="KosalaraksaP , JanthepP , JirapraditthaJ , TaksaphanS , KiatchoosakunP . Once versus twice daily dose of gentamicin therapy in Thai neonates. Journal of the Medical Association of Thailand2004;87(4):372‐6. ">Kosalaraksa 2004</a> reported a statistically significant difference favouring 'once a day' gentamicin compared to 'multiple doses a day' gentamicin. Meta‐analysis of all studies showed a statistically significant difference indicating that 'once a day' gentamicin groups are associated with fewer failures than 'multiple doses a day' regimens (typical RR 0.38, 95% CI 0.27 to 0.55; typical RD −0.22, 95% CI −0.29 to −0.15; NNTB = 4; 11 trials; N = 503). </p> <div class="figure" id="CD005091-fig-0005"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 5</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 1 All studies comparing 'once a day' versus 'multiple doses a day' regimen, outcome: 1.3 Failure to achieve trough levels of ≤ 2 microgram/ml." data-id="CD005091-fig-0005" src="/cdsr/doi/10.1002/14651858.CD005091.pub4/media/CDSR/CD005091/image_n/nCD005091-AFig-FIG05.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 1 All studies comparing 'once a day' versus 'multiple doses a day' regimen, outcome: 1.3 Failure to achieve trough levels of ≤ 2 microgram/ml. </p> </div> </div> </div> </section> </section> </section> <section id="CD005091-sec-0071"> <h4 class="title">Secondary outcome measures</h4> <section id="CD005091-sec-0072"> <h5 class="title">Ototoxicity (Outcome 1.4)</h5> <p> <ul id="CD005091-list-0010"> <li> <p>Auditory: defined as changes in pure tone audiometry or brain‐stem evoked auditory responses or otoacoustic emissions or any other validated hearing tests. </p> </li> <li> <p>Vestibular: defined as changes in electronystagmography or any other validated vestibular function test. </p> </li> </ul> </p> <p>Four studies assessed auditory toxicity (<a href="./references#CD005091-fig-0010" title="">Analysis 1.4</a>) (<a href="./references#CD005091-bbs2-0003" title="deAlba RomeroC , Gomez CastilloE , Manzanares SecadesC , Rodriguez LopezJ , Arreaza LopezL , Saenz ValienteP . Once daily gentamicin dosing in neonates. Pediatric Infectious Disease Journal1998;17(12):1169‐71. ">de Alba Romero 1998</a>; <a href="./references#CD005091-bbs2-0011" title="ThureenPJ , ReiterPD , GresoresA , StolpmanNM , KawatoK , HallDM . Once‐ versus twice‐daily gentamicin dosing in neonates &gt;=34 weeks' gestation: cost‐effectiveness analyses. Pediatrics1999;103(3):594‐8. ">Thureen 1999</a>; <a href="./references#CD005091-bbs2-0001" title="AgarwalG , RastogiA , PyatiS , WilksA , PildesRS . Comparison of once‐daily versus twice‐daily gentamicin dosing regimens in infants &gt; or = 2500 g. Journal of Perinatology2002;22(4):268‐74. ">Agarwal 2002</a>; <a href="./references#CD005091-bbs2-0004" title="HaganR . Gentamicin in neonates: single vs multiple doses. Abstract book PSANZ 2002. 2002. ">Hagan 2002</a>). <a href="./references#CD005091-bbs2-0011" title="ThureenPJ , ReiterPD , GresoresA , StolpmanNM , KawatoK , HallDM . Once‐ versus twice‐daily gentamicin dosing in neonates &gt;=34 weeks' gestation: cost‐effectiveness analyses. Pediatrics1999;103(3):594‐8. ">Thureen 1999</a> replied that all infants in both the 'once a day' and 'multiple doses a day' gentamicin groups passed hearing screening tests. <a href="./references#CD005091-bbs2-0004" title="HaganR . Gentamicin in neonates: single vs multiple doses. Abstract book PSANZ 2002. 2002. ">Hagan 2002</a> used otoacoustic emission tests both prior to the first dose and after the third dose of gentamicin and did not find evidence of ototoxicity in either group. <a href="./references#CD005091-bbs2-0001" title="AgarwalG , RastogiA , PyatiS , WilksA , PildesRS . Comparison of once‐daily versus twice‐daily gentamicin dosing regimens in infants &gt; or = 2500 g. Journal of Perinatology2002;22(4):268‐74. ">Agarwal 2002</a> performed hearing screening tests prior to discharge; none of their study infants failed hearing tests. <a href="./references#CD005091-bbs2-0003" title="deAlba RomeroC , Gomez CastilloE , Manzanares SecadesC , Rodriguez LopezJ , Arreaza LopezL , Saenz ValienteP . Once daily gentamicin dosing in neonates. Pediatric Infectious Disease Journal1998;17(12):1169‐71. ">de Alba Romero 1998</a> reported two cases of ototoxicity out of 13 in the 'once a day' group compared to one out of 11 in the 'multiple doses a day' regimen. <a href="./references#CD005091-bbs2-0002" title="ChotigeatU , NarongsantiA , AyudhyaDP . Gentamicin in neonatal infection: once versus twice daily dosage. Journal of Medical Association of Thailand2001;84(8):1109‐15. ">Chotigeat 2001</a> performed the tests for ototoxicity but did not report the results. Meta‐analysis of all the studies showed no statistically significant differences in ototoxicity between the two groups (typical RR 1.69, 95% CI 0.18 to 16.25; typical RD 0.01, 95% CI −0.04 to 0.05; 5 trials; N = 214). </p> <p>Vestibular toxicity was not tested by any of the studies.</p> </section> <section id="CD005091-sec-0073"> <h5 class="title">Nephrotoxicity (Outcome 1.5)</h5> <p> <ul id="CD005091-list-0011"> <li> <p>Primary: any increase in serum creatinine levels or decrease in creatinine clearance, with thresholds as defined in each study. </p> </li> <li> <p>Secondary: urinary excretion of proteins (retinal binding protein, beta‐2 microglobulin, Clara cell protein, microalbumin, N‐Acetyl‐Beta‐D‐glucosaminidase, alkaline phosphatase, alanine aminopeptidase, or gamma‐glutamyl transferase) or phospholipids. </p> </li> </ul> </p> <p><a href="./references#CD005091-bbs2-0009" title="SkopnikH , WallrafR , NiesB , TrosterK , HeimannG . Pharmacokinetics and antibacterial activity of daily gentamicin. Archives of Diseases in Childhood1992;67(1 Spec No):57‐61. ">Skopnik 1992</a>, <a href="./references#CD005091-bbs2-0005" title="HayaniKC , HatzopoulosFK , FrankAL , ThummalaMR , HantschMJ , SchatzBM , et al. Pharmacokinetics of once‐daily dosing of gentamicin in neonates. Journal of Pediatrics1997;131(1 Pt 1):76‐80. ">Hayani 1997</a>, <a href="./references#CD005091-bbs2-0007" title="KrishnanL , GeorgeSA . Gentamicin therapy in preterms: a comparison of two dosage regimens. Indian Pediatrics1997;34(12):1075‐80. ">Krishnan 1997</a>, <a href="./references#CD005091-bbs2-0003" title="deAlba RomeroC , Gomez CastilloE , Manzanares SecadesC , Rodriguez LopezJ , Arreaza LopezL , Saenz ValienteP . Once daily gentamicin dosing in neonates. Pediatric Infectious Disease Journal1998;17(12):1169‐71. ">de Alba Romero 1998</a>, <a href="./references#CD005091-bbs2-0002" title="ChotigeatU , NarongsantiA , AyudhyaDP . Gentamicin in neonatal infection: once versus twice daily dosage. Journal of Medical Association of Thailand2001;84(8):1109‐15. ">Chotigeat 2001</a>, <a href="./references#CD005091-bbs2-0001" title="AgarwalG , RastogiA , PyatiS , WilksA , PildesRS . Comparison of once‐daily versus twice‐daily gentamicin dosing regimens in infants &gt; or = 2500 g. Journal of Perinatology2002;22(4):268‐74. ">Agarwal 2002</a>, <a href="./references#CD005091-bbs2-0004" title="HaganR . Gentamicin in neonates: single vs multiple doses. Abstract book PSANZ 2002. 2002. ">Hagan 2002</a>, <a href="./references#CD005091-bbs2-0008" title="MironD , SteinfeldM , HasaneinJ , FelszerC , ReichD . Tolerability of once‐daily‐dosing of intravenous gentamicin in preterm neonates born at 32‐37 weeks of gestation. Harefuah2003;142(6):413‐5. ">Miron 2003</a> and <a href="./references#CD005091-bbs2-0006" title="KosalaraksaP , JanthepP , JirapraditthaJ , TaksaphanS , KiatchoosakunP . Once versus twice daily dose of gentamicin therapy in Thai neonates. Journal of the Medical Association of Thailand2004;87(4):372‐6. ">Kosalaraksa 2004</a> reported this outcome (<a href="#CD005091-fig-0006">Figure 6</a>). <a href="./references#CD005091-bbs2-0001" title="AgarwalG , RastogiA , PyatiS , WilksA , PildesRS . Comparison of once‐daily versus twice‐daily gentamicin dosing regimens in infants &gt; or = 2500 g. Journal of Perinatology2002;22(4):268‐74. ">Agarwal 2002</a> monitored renal functions by measuring 24‐hour urine output on days one, two and three of therapy. Serum electrolytes, blood urea nitrogen and serum creatinine were measured on days two and three of the study. Creatinine clearance and FENa were measured on days two and three of therapy. There were no significant differences between the two groups in all the outcomes measured. <a href="./references#CD005091-bbs2-0002" title="ChotigeatU , NarongsantiA , AyudhyaDP . Gentamicin in neonatal infection: once versus twice daily dosage. Journal of Medical Association of Thailand2001;84(8):1109‐15. ">Chotigeat 2001</a> measured serum creatinine before the beginning of treatment and on the third day and the last day of therapy; there was no significant difference between the two dosage regimens. <a href="./references#CD005091-bbs2-0004" title="HaganR . Gentamicin in neonates: single vs multiple doses. Abstract book PSANZ 2002. 2002. ">Hagan 2002</a> measured serum creatinine levels before the beginning of study and subsequently on a daily basis till the completion of treatment; there was no significant difference between the two dosage regimens. <a href="./references#CD005091-bbs2-0005" title="HayaniKC , HatzopoulosFK , FrankAL , ThummalaMR , HantschMJ , SchatzBM , et al. Pharmacokinetics of once‐daily dosing of gentamicin in neonates. Journal of Pediatrics1997;131(1 Pt 1):76‐80. ">Hayani 1997</a> measured serum creatinine and GFR before therapy and on day two or three of therapy. They also measured urinary beta‐2 microglobulin levels before and after completion of therapy. There was no significant difference between the two regimens. <a href="./references#CD005091-bbs2-0006" title="KosalaraksaP , JanthepP , JirapraditthaJ , TaksaphanS , KiatchoosakunP . Once versus twice daily dose of gentamicin therapy in Thai neonates. Journal of the Medical Association of Thailand2004;87(4):372‐6. ">Kosalaraksa 2004</a> measured serum creatinine on day zero, three and seven or the last day of therapy; there was no nephrotoxicity in either group. <a href="./references#CD005091-bbs2-0007" title="KrishnanL , GeorgeSA . Gentamicin therapy in preterms: a comparison of two dosage regimens. Indian Pediatrics1997;34(12):1075‐80. ">Krishnan 1997</a> measured serum creatinine before and at the end of therapy and found no significant difference in creatinine levels between the two groups. There was no nephrotoxicity in either group. <a href="./references#CD005091-bbs2-0008" title="MironD , SteinfeldM , HasaneinJ , FelszerC , ReichD . Tolerability of once‐daily‐dosing of intravenous gentamicin in preterm neonates born at 32‐37 weeks of gestation. Harefuah2003;142(6):413‐5. ">Miron 2003</a> measured serum and urine creatinine and sodium concentrations, urinary lysozyme excretion, glomerular filtration rate and fractional excretion of sodium at 72 to 96 hours of therapy. The values were not significantly different between the two groups; and none of the babies in either group developed nephrotoxicity. <a href="./references#CD005091-bbs2-0003" title="deAlba RomeroC , Gomez CastilloE , Manzanares SecadesC , Rodriguez LopezJ , Arreaza LopezL , Saenz ValienteP . Once daily gentamicin dosing in neonates. Pediatric Infectious Disease Journal1998;17(12):1169‐71. ">de Alba Romero 1998</a> measured the N‐Acetyl‐Beta‐D‐glucosaminidase:creatinine ratio as a sensitive indicator of gentamicin‐induced nephrotoxicity. First‐morning urine within the first two days and on the seventh day of treatment was analyzed. The enzyme levels increased in urine in both groups, more so in the 'multiple doses a day' gentamicin group; however, there was no significant difference. <a href="./references#CD005091-bbs2-0009" title="SkopnikH , WallrafR , NiesB , TrosterK , HeimannG . Pharmacokinetics and antibacterial activity of daily gentamicin. Archives of Diseases in Childhood1992;67(1 Spec No):57‐61. ">Skopnik 1992</a> measured urinary aminopeptidase levels as a marker of nephrotoxicity and found that it was increased in both groups in the same pattern during and after discontinuation of gentamicin therapy. </p> <div class="figure" id="CD005091-fig-0006"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 6</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 1 All studies comparing 'once a day' versus 'multiple doses a day' regimen, outcome: 1.5 Nephrotoxicity." data-id="CD005091-fig-0006" src="/cdsr/doi/10.1002/14651858.CD005091.pub4/media/CDSR/CD005091/image_n/nCD005091-AFig-FIG06.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 1 All studies comparing 'once a day' versus 'multiple doses a day' regimen, outcome: 1.5 Nephrotoxicity. </p> </div> </div> </div> </section> <section id="CD005091-sec-0074"> <h5 class="title">Treatment failure (Outcome 1.6)</h5> <p>Treatment failure was defined as persistent positive blood/body fluid or tissue cultures which led to addition of new antibiotic (<a href="./references#CD005091-fig-0012" title="">Analysis 1.6</a>). <a href="./references#CD005091-bbs2-0003" title="deAlba RomeroC , Gomez CastilloE , Manzanares SecadesC , Rodriguez LopezJ , Arreaza LopezL , Saenz ValienteP . Once daily gentamicin dosing in neonates. Pediatric Infectious Disease Journal1998;17(12):1169‐71. ">de Alba Romero 1998</a>, <a href="./references#CD005091-bbs2-0004" title="HaganR . Gentamicin in neonates: single vs multiple doses. Abstract book PSANZ 2002. 2002. ">Hagan 2002</a> and <a href="./references#CD005091-bbs2-0008" title="MironD , SteinfeldM , HasaneinJ , FelszerC , ReichD . Tolerability of once‐daily‐dosing of intravenous gentamicin in preterm neonates born at 32‐37 weeks of gestation. Harefuah2003;142(6):413‐5. ">Miron 2003</a> reported in total 36 infants with proven sepsis. There were no treatment failures in either the 'once a day' or the 'multiple doses a day' regimens (typical RR 0.0, 95% CI 0.0 to 0.0; typical RD 0.00, 95% CI −0.19 to 0.19; 3 trials; N = 36). </p> </section> <section id="CD005091-sec-0075"> <h5 class="title">Actual peak levels (mean and SD) attained (µg/ml) (Outcome 1.7)</h5> <p>Peak levels were defined as levels measured at 0.5 to 1 hour after a dose of gentamicin (<a href="./references#CD005091-fig-0013" title="">Analysis 1.7</a>). All studies except <a href="./references#CD005091-bbs2-0010" title="SolomonR , KuruvillaKA , JobV , SelvakumarR , JeyaseelanL , KanagasabapathyAS , et al. Randomized controlled trial of once vs. twice daily gentamicin therapy in newborn. Indian Pediatrics1999;36(2):133‐7. ">Solomon 1999</a> reported this outcome. All studies except <a href="./references#CD005091-bbs2-0007" title="KrishnanL , GeorgeSA . Gentamicin therapy in preterms: a comparison of two dosage regimens. Indian Pediatrics1997;34(12):1075‐80. ">Krishnan 1997</a> reported a statistically significant difference with higher peak levels attained in the 'once a day' gentamicin regimen. Meta‐analysis of the 10 studies involving a total of 440 infants showed a statistically significant difference between the 'once a day' and the 'multiple doses a day' gentamicin regimens with higher peak levels attained in the 'once a day' regimens (MD 2.58, 95% CI 2.26 to 2.89; 10 trials; N = 440). Analysis showed significant heterogeneity and hence should be interpreted with caution. </p> </section> <section id="CD005091-sec-0076"> <h5 class="title">Actual trough levels (mean and SD) attained (µg/ml) (Outcome 1.8)</h5> <p>Trough levels are defined as levels measured prior to within one hour of giving any dose of gentamicin (except the initial dose) (<a href="./references#CD005091-fig-0014" title="">Analysis 1.8</a>). All studies except <a href="./references#CD005091-bbs2-0010" title="SolomonR , KuruvillaKA , JobV , SelvakumarR , JeyaseelanL , KanagasabapathyAS , et al. Randomized controlled trial of once vs. twice daily gentamicin therapy in newborn. Indian Pediatrics1999;36(2):133‐7. ">Solomon 1999</a> reported this outcome. All studies except <a href="./references#CD005091-bbs2-0004" title="HaganR . Gentamicin in neonates: single vs multiple doses. Abstract book PSANZ 2002. 2002. ">Hagan 2002</a> and <a href="./references#CD005091-bbs2-0005" title="HayaniKC , HatzopoulosFK , FrankAL , ThummalaMR , HantschMJ , SchatzBM , et al. Pharmacokinetics of once‐daily dosing of gentamicin in neonates. Journal of Pediatrics1997;131(1 Pt 1):76‐80. ">Hayani 1997</a> showed statistically significant lower trough levels in the 'once a day' compared to the 'multiple doses a day' gentamicin regimens. Meta‐analysis of all the studies showed statistically significant lower trough levels in the 'once a day' regimen versus the 'multiple doses a day' gentamicin regimen (MD −0.57, 95% CI −0.69 to −0.44; 10 trials; N = 440). Analysis showed significant heterogeneity and hence should be interpreted with caution. </p> </section> <section id="CD005091-sec-0077"> <h5 class="title">Subgroup analysis of intramuscular gentamicin</h5> <p><a href="./references#CD005091-bbs2-0005" title="HayaniKC , HatzopoulosFK , FrankAL , ThummalaMR , HantschMJ , SchatzBM , et al. Pharmacokinetics of once‐daily dosing of gentamicin in neonates. Journal of Pediatrics1997;131(1 Pt 1):76‐80. ">Hayani 1997</a> and <a href="./references#CD005091-bbs2-0004" title="HaganR . Gentamicin in neonates: single vs multiple doses. Abstract book PSANZ 2002. 2002. ">Hagan 2002</a> used gentamicin intramuscularly in some of their study infants. Separate data for the intramuscular gentamicin was not available from <a href="./references#CD005091-bbs2-0004" title="HaganR . Gentamicin in neonates: single vs multiple doses. Abstract book PSANZ 2002. 2002. ">Hagan 2002</a>. <a href="./references#CD005091-bbs2-0005" title="HayaniKC , HatzopoulosFK , FrankAL , ThummalaMR , HantschMJ , SchatzBM , et al. Pharmacokinetics of once‐daily dosing of gentamicin in neonates. Journal of Pediatrics1997;131(1 Pt 1):76‐80. ">Hayani 1997</a> reported the outcomes on four infants with 'once a day' gentamicin, but combined the data for intramuscular and intravenous gentamicin in the 'multiple doses a day' regimen because there was no significant difference in the pharmacokinetic parameters between these groups. The peak gentamicin levels in the 'once a day ' group were significantly higher (P &lt; 0.05) than the 'multiple doses a day' group (11.2 ± 2.0 µg/ml versus 6.6 ± 1.3 µg/ml). The trough levels were significantly lower (P &lt; 0.05) in the 'once a day' group compared to the 'multiple doses a day' group (1.1 ± 0.3 µg/ml versus 1.7 ± 0.5 µg/ml). </p> </section> <section id="CD005091-sec-0078"> <h5 class="title">Subgroup analysis of infants with proven sepsis</h5> <p>As previously noted, very few infants had proven sepsis in the included studies. In the <a href="./references#CD005091-bbs2-0003" title="deAlba RomeroC , Gomez CastilloE , Manzanares SecadesC , Rodriguez LopezJ , Arreaza LopezL , Saenz ValienteP . Once daily gentamicin dosing in neonates. Pediatric Infectious Disease Journal1998;17(12):1169‐71. ">de Alba Romero 1998</a> study, 14 infants (42%) in the 'once a day' group and 15 infants (47%) in the 'multiple doses a day' group had bacteriological sepsis. All infants had clearance of sepsis in both groups. Only one infant had proven sepsis in the study by <a href="./references#CD005091-bbs2-0005" title="HayaniKC , HatzopoulosFK , FrankAL , ThummalaMR , HantschMJ , SchatzBM , et al. Pharmacokinetics of once‐daily dosing of gentamicin in neonates. Journal of Pediatrics1997;131(1 Pt 1):76‐80. ">Hayani 1997</a>; the outcome of this infant was not reported. Two infants had proven Gram‐positive sepsis in the study by <a href="./references#CD005091-bbs2-0006" title="KosalaraksaP , JanthepP , JirapraditthaJ , TaksaphanS , KiatchoosakunP . Once versus twice daily dose of gentamicin therapy in Thai neonates. Journal of the Medical Association of Thailand2004;87(4):372‐6. ">Kosalaraksa 2004</a>, one in each group of the 'once a day' and the 'multiple doses a day' regimen; however, they were excluded from analysis. <a href="./references#CD005091-bbs2-0004" title="HaganR . Gentamicin in neonates: single vs multiple doses. Abstract book PSANZ 2002. 2002. ">Hagan 2002</a>'s study reported that all five infants with proven bacteriological sepsis in the 'once a day' gentamicin group responded by clearance of sepsis. There were no cases of proven sepsis in the 'multiple doses a day' gentamicin group. <a href="./references#CD005091-bbs2-0008" title="MironD , SteinfeldM , HasaneinJ , FelszerC , ReichD . Tolerability of once‐daily‐dosing of intravenous gentamicin in preterm neonates born at 32‐37 weeks of gestation. Harefuah2003;142(6):413‐5. ">Miron 2003</a> had one infant in each group with proven sepsis; both infants had clearance of sepsis after institution of antibiotic therapy. Meta‐analysis of all the studies did not show significant difference between the two groups (typical RD 0.00, 95% CI −0.19 to 0.19); 3 trials, N = 36). Other outcomes were not reported for this subgroup of infants. </p> </section> <section id="CD005091-sec-0079"> <h5 class="title">Subgroup analysis of infants less than 32 weeks' gestation</h5> <p><a href="./references#CD005091-bbs2-0003" title="deAlba RomeroC , Gomez CastilloE , Manzanares SecadesC , Rodriguez LopezJ , Arreaza LopezL , Saenz ValienteP . Once daily gentamicin dosing in neonates. Pediatric Infectious Disease Journal1998;17(12):1169‐71. ">de Alba Romero 1998</a> had seven infants with gestational age less than 32 weeks; all were treated for suspected sepsis. All infants in both groups achieved peak levels of more than 5 µg/ml. Three out of five infants in the 'once a day' group had toxic trough levels of more than 2 µg/ml. Both infants in the 'multiple doses a day' regimen had toxic trough levels of more than 2 µg/ml. No other study enrolled infants of less than 32 weeks' gestation. </p> </section> <section id="CD005091-sec-0080"> <h5 class="title">Subgroup analysis of infants in whom loading dose was used in both 'once a day' and 'multiple doses a day' regimen </h5> <p>None of the studies used a loading dose of gentamicin in both the study and control regimens. </p> <p>Sensitivity analysis by excluding studies where trial participants were of extremely low gestational age could not be done because no studies included such infants. </p> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD005091-sec-0081" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD005091-sec-0081"></div> <section id="CD005091-sec-0082"> <h3 class="title" id="CD005091-sec-0082">Summary of main results</h3> <p>The outcome of 574 neonates from 11 RCTs comparing 'once a day' versus 'multiple doses a day' gentamicin have been reported in this review. For the primary outcome of 'Clearance of proven sepsis', there was no statistically significant difference between the 'once a day' and 'multiple doses a day' regimens of gentamicin. Both treatment regimes were successful at treating infants with proven sepsis. However, the numbers were too small to arrive at definite conclusions. This is as expected because only a very small percentage of neonates with suspected sepsis have a culture‐positive infection (<a href="./references#CD005091-bbs2-0089" title="StollBJ , GordonT , KoronesSB , ShankaranS , TysonJE , BauerCR , et al. Early‐onset sepsis in very low birth weight neonates: a report from the National Institute of Child Health and Human Development Neonatal Research Network. Journal of Pediatrics1996;129(1):72‐80. ">Stoll 1996a</a>; <a href="./references#CD005091-bbs2-0090" title="StollBJ , GordonT , KoronesSB , ShankaranS , TysonJE , BauerCR , et al. Late‐onset sepsis in very low birth weight neonates: a report from the National Institute of Child Health and Human Development Neonatal Research Network. Journal of Pediatrics1996;129(1):63‐71. ">Stoll 1996b</a>). For the primary outcomes of 'Failure to attain peak levels of at least 5 µg/ml', and 'Failure to achieve trough levels of &lt; 2 µg/ml', meta‐analysis showed a statistically significant difference favouring the 'once a day' gentamicin group. 'Once a day' gentamicin was associated with lower pharmacokinetic failure rates than the 'multiple doses a day' regimen. </p> <p>For the secondary outcomes of 'Actual peak levels' and 'Actual trough levels' attained, meta‐analysis showed that a 'once a day' regimen achieved higher peak levels and lower trough levels compared to a 'multiple doses a day' regimen. However significant heterogeneity was noticed for these two outcomes and therefore these results need to be interpreted with caution. Heterogeneity was explored by re‐checking entered data and by excluding individual studies one at a time. Individual trials were studied in detail to explore the cause of heterogeneity. <a href="./references#CD005091-bbs2-0007" title="KrishnanL , GeorgeSA . Gentamicin therapy in preterms: a comparison of two dosage regimens. Indian Pediatrics1997;34(12):1075‐80. ">Krishnan 1997</a>, <a href="./references#CD005091-bbs2-0010" title="SolomonR , KuruvillaKA , JobV , SelvakumarR , JeyaseelanL , KanagasabapathyAS , et al. Randomized controlled trial of once vs. twice daily gentamicin therapy in newborn. Indian Pediatrics1999;36(2):133‐7. ">Solomon 1999</a> and <a href="./references#CD005091-bbs2-0008" title="MironD , SteinfeldM , HasaneinJ , FelszerC , ReichD . Tolerability of once‐daily‐dosing of intravenous gentamicin in preterm neonates born at 32‐37 weeks of gestation. Harefuah2003;142(6):413‐5. ">Miron 2003</a> enrolled infants of more than 32 weeks' gestation. <a href="./references#CD005091-bbs2-0005" title="HayaniKC , HatzopoulosFK , FrankAL , ThummalaMR , HantschMJ , SchatzBM , et al. Pharmacokinetics of once‐daily dosing of gentamicin in neonates. Journal of Pediatrics1997;131(1 Pt 1):76‐80. ">Hayani 1997</a>, <a href="./references#CD005091-bbs2-0011" title="ThureenPJ , ReiterPD , GresoresA , StolpmanNM , KawatoK , HallDM . Once‐ versus twice‐daily gentamicin dosing in neonates &gt;=34 weeks' gestation: cost‐effectiveness analyses. Pediatrics1999;103(3):594‐8. ">Thureen 1999</a>, <a href="./references#CD005091-bbs2-0002" title="ChotigeatU , NarongsantiA , AyudhyaDP . Gentamicin in neonatal infection: once versus twice daily dosage. Journal of Medical Association of Thailand2001;84(8):1109‐15. ">Chotigeat 2001</a>, <a href="./references#CD005091-bbs2-0004" title="HaganR . Gentamicin in neonates: single vs multiple doses. Abstract book PSANZ 2002. 2002. ">Hagan 2002</a> and <a href="./references#CD005091-bbs2-0006" title="KosalaraksaP , JanthepP , JirapraditthaJ , TaksaphanS , KiatchoosakunP . Once versus twice daily dose of gentamicin therapy in Thai neonates. Journal of the Medical Association of Thailand2004;87(4):372‐6. ">Kosalaraksa 2004</a> enrolled infants of more than 34 weeks' gestation. <a href="./references#CD005091-bbs2-0001" title="AgarwalG , RastogiA , PyatiS , WilksA , PildesRS . Comparison of once‐daily versus twice‐daily gentamicin dosing regimens in infants &gt; or = 2500 g. Journal of Perinatology2002;22(4):268‐74. ">Agarwal 2002</a> enrolled infants whose birth weight was 2500 g or above regardless of gestation age. <a href="./references#CD005091-bbs2-0009" title="SkopnikH , WallrafR , NiesB , TrosterK , HeimannG . Pharmacokinetics and antibacterial activity of daily gentamicin. Archives of Diseases in Childhood1992;67(1 Spec No):57‐61. ">Skopnik 1992</a> enrolled only full‐term neonates. <a href="./references#CD005091-bbs2-0003" title="deAlba RomeroC , Gomez CastilloE , Manzanares SecadesC , Rodriguez LopezJ , Arreaza LopezL , Saenz ValienteP . Once daily gentamicin dosing in neonates. Pediatric Infectious Disease Journal1998;17(12):1169‐71. ">de Alba Romero 1998</a> enrolled infants with birth weight of 1200 g or above. These differences in gestational age and birth weight might have contributed to heterogeneity. All studies used a similar dose of gentamicin (4 to 5 mg/kg/day). Timing of collection of the blood samples for trough levels was the same in all the studies (within 30 minutes of administration of the next dose). Samples for peak levels were collected between 30 to 60 minutes after administration of the dose. The day of therapy on which samples were collected varied between day one to day five; this variation in the day and time of collection of the samples may also have led to heterogeneity. <a href="./references#CD005091-bbs2-0004" title="HaganR . Gentamicin in neonates: single vs multiple doses. Abstract book PSANZ 2002. 2002. ">Hagan 2002</a> and <a href="./references#CD005091-bbs2-0005" title="HayaniKC , HatzopoulosFK , FrankAL , ThummalaMR , HantschMJ , SchatzBM , et al. Pharmacokinetics of once‐daily dosing of gentamicin in neonates. Journal of Pediatrics1997;131(1 Pt 1):76‐80. ">Hayani 1997</a> used gentamicin both intramuscularly and intravenously; however, significant heterogeneity still remained even when these two studies were excluded from the meta‐analysis. Results remained the same when data were re‐analysed using a random‐effects model instead of a fixed‐effect model. </p> <p><a href="./references#CD005091-bbs2-0003" title="deAlba RomeroC , Gomez CastilloE , Manzanares SecadesC , Rodriguez LopezJ , Arreaza LopezL , Saenz ValienteP . Once daily gentamicin dosing in neonates. Pediatric Infectious Disease Journal1998;17(12):1169‐71. ">de Alba Romero 1998</a> reported less nephrotoxicity in the 'once a day' gentamicin regimen compared to the 'multiple doses a day' regimen. They measured urinary levels of N‐Acetyl‐Beta‐D‐glucosaminidase as the marker of nephrotoxicity. All other seven studies found no difference in the risk of nephrotoxicity between 'once a day' and 'multiple doses a day' gentamicin regimens. In a prospective study, <a href="./references#CD005091-bbs2-0083" title="NielsenEI , SandströmM , HonoréPH , EwaldU , FribergLE . Developmental pharmacokinetics of gentamicin in preterm and term neonates: population modelling of a prospective study. Clinical Pharmacokinetics2009;48(4):253‐63. ">Nielsen 2009</a> evaluated the use of cystatin C along with serum creatinine as a marker of gentamicin clearance and concluded that neither of them correlated with gentamicin clearance. They also concluded that serum creatinine and cystatin C were not predictive markers of renal function in their population set (<a href="./references#CD005091-bbs2-0083" title="NielsenEI , SandströmM , HonoréPH , EwaldU , FribergLE . Developmental pharmacokinetics of gentamicin in preterm and term neonates: population modelling of a prospective study. Clinical Pharmacokinetics2009;48(4):253‐63. ">Nielsen 2009</a>). <a href="./references#CD005091-bbs2-0052" title="CosciaA , MaiorcaD , MartanoC , RossiC , AppinoI , CirinaP , et al. Use of netilmicin once or twice daily in preterm newborns: evaluation of nephrotoxicity by urinary alpha 1‐microglobulin and retinol binding protein. Journal of Chemotherapy2008;20(3):324‐6. ">Coscia 2008</a> evaluated the nephrotoxic effects of 'once a day' netilmicin with multiple doses a day in preterm neonates (GA &lt; 37 weeks). The 'once a day' regimen had the same low rates of nephrotoxicity as multiple doses a day, suggesting the possible advantages of the 'once a day' regimen. An RCT in adults measured urinary alanine aminopeptidase (AAP) and N‐Acetyl‐Beta‐D‐glucosaminidase (NAG) as markers of nephrotoxicity and found that 'once a day' tobramycin was less nephrotoxic than a 'multiple doses a day' regimen (<a href="./references#CD005091-bbs2-0084" title="OlsenKM , RudisMI , RebuckJA , HaraJ , GelmontD , MehdianR , NelsonC , RuppME . Effect of once‐daily dosing vs. multiple daily dosing of tobramycin on enzyme markers of nephrotoxicity. Critical Care Medicine2004;32:1678‐82. ">Olsen 2004</a>). Accurately evaluating nephrotoxicity within a neonatal population remains challenging as renal function undergoes rapid maturation in the early weeks after birth and preterm neonates have an initial rise in creatinine (<a href="./references#CD005091-bbs2-0047" title="BlackburnST . Renal function in the neonate. Journal of Perinatal and Neonatal Nursing1994;8(1):37‐47. [PUBMED: 8006805] ">Blackburn 1994</a>; <a href="./references#CD005091-bbs2-0071" title="KentA , TurnerMA , SharlandM , HeathPT . Aminoglycoside toxicity in neonates: something to worry about?. Expert Review of Anti‐infective Therapy2014;12(3):319‐31. [PUBMED: 24455994] ">Kent 2014</a>). The GFR increases rapidly at birth and doubles during the first few weeks after birth (<a href="./references#CD005091-bbs2-0047" title="BlackburnST . Renal function in the neonate. Journal of Perinatal and Neonatal Nursing1994;8(1):37‐47. [PUBMED: 8006805] ">Blackburn 1994</a>). Therefore, using creatinine or GFR to determine aminoglycoside‐induced nephrotoxicity may be suboptimal in neonates. As proximal tubule toxicity is the primary mechanism of aminoglycoside nephrotoxicity, urinary biomarkers have been used to measure nephrotoxicity. However, the clinical significance of raised urinary levels associated with normal plasma creatinine levels and normal urine output is unknown (<a href="./references#CD005091-bbs2-0071" title="KentA , TurnerMA , SharlandM , HeathPT . Aminoglycoside toxicity in neonates: something to worry about?. Expert Review of Anti‐infective Therapy2014;12(3):319‐31. [PUBMED: 24455994] ">Kent 2014</a>). <a href="./references#CD005091-bbs2-0078" title="McWilliamsSJ , AntoineDJ , SabbisettiV , TurnerMA , FarragherT , BonventreJV , et al. Mechanism‐based urinary biomarkers to identify the potential for aminoglycoside‐induced nephrotoxicity in premature neonates: a proof‐of‐concept study. PLoS One2012;7(8):e43809. [PUBMED: 22937100] ">McWilliams 2012</a> studied urinary kidney injury molecule 1 (KIM‐1) and other biomarkers in neonates receiving gentamicin therapy. Although univariate analysis indicated significant association between aminoglycoside toxicity and urinary KIM‐1, urinary N‐Acetyl‐Beta‐D‐glycosaminidase, and urinary neutrophil gelatinase‐associated lipocalin, in multivariate analysis only urinary KIM‐1 elevation was significantly correlated with aminoglycoside treatment, whereas other urinary biomarkers fell out of significance. </p> <p>Only five studies assessed, and four studies reported, auditory toxicity. No difference was noted between the two groups. Vestibular toxicity was not assessed in any of the studies possibly due to difficulties assessing vestibular function in neonates. Our results are similar to the findings of the systematic review by <a href="./references#CD005091-bbs2-0071" title="KentA , TurnerMA , SharlandM , HeathPT . Aminoglycoside toxicity in neonates: something to worry about?. Expert Review of Anti‐infective Therapy2014;12(3):319‐31. [PUBMED: 24455994] ">Kent 2014</a>, (gentamicin (n) = 577) that found no clear association between peak or trough levels and ototoxicity in neonates. In that review, 22 children (3.8%) were identified as having gentamicin ototoxicity but the authors hypothesized the possibility of a potential overestimation as no repeat tests were performed for verifications following an initial failed hearing screen. <a href="./references#CD005091-bbs2-0087" title="SetiabudyR , SuwentoR , RundjanL , YasinFH , LouisaM , DwijayantiA , et al. Lack of relationship between the serum concentration of aminoglycosides and ototoxicity in neonates. International Journal of Clinical Pharmacology and Therapeutics2013;51(5):401‐6. [PUBMED: 23557866] ">Setiabudy 2013</a> assessed hearing function in neonates with sepsis receiving 24 to 48 hourly aminoglycides using an otoacoustic emission instrument and found no relationship between trough levels and ototoxocity. Similary, <a href="./references#CD005091-bbs2-0056" title="El‐BarbaryMN , IsmailRIH , IbrahimAAA . Gentamicin extended interval regimen and ototoxicity in neonates. International Journal of Pediatric Otorhinolaryngology2015;79(8):1294‐8. [PUBMED: 26071016] ">El‐Barbary 2015</a> compared NICU neonates receiving 'once a day' gentamicin to no gentamicin and found that the incidence of hearing loss is comparable in each arm; and longer duration (&gt; 5 days) had no impact on their findings. While these findings are reassuring, it is important to exercise caution and use gentamicin only for the minimum duration possible in neonates. In children, the chances of gentamicin ototoxicity is reported to be greater in those who receive the drug for a longer duration (<a href="./references#CD005091-bbs2-0071" title="KentA , TurnerMA , SharlandM , HeathPT . Aminoglycoside toxicity in neonates: something to worry about?. Expert Review of Anti‐infective Therapy2014;12(3):319‐31. [PUBMED: 24455994] ">Kent 2014</a>). The limitations of the included studies in our review were lack of long‐term follow‐up testing and failure to take into account other potential risk factors such as concomitant use of ototoxic agents. </p> <p>A 'once a day' gentamicin regimen requires less pharmacy preparation time and less nursing administration time. <a href="./references#CD005091-bbs2-0011" title="ThureenPJ , ReiterPD , GresoresA , StolpmanNM , KawatoK , HallDM . Once‐ versus twice‐daily gentamicin dosing in neonates &gt;=34 weeks' gestation: cost‐effectiveness analyses. Pediatrics1999;103(3):594‐8. ">Thureen 1999</a> evaluated the cost‐effectiveness analysis of 'once a day' gentamicin among neonates and found that a 'once a day' gentamicin regimen was more cost effective than a 'multiple doses a day' regimen. Individualized dosing regimens may be ideal, but are more expensive as they require more frequent measurement of gentamicin levels. Measurement of gentamicin levels is the major contributor to the expense of administering this relatively inexpensive drug (<a href="./references#CD005091-bbs2-0011" title="ThureenPJ , ReiterPD , GresoresA , StolpmanNM , KawatoK , HallDM . Once‐ versus twice‐daily gentamicin dosing in neonates &gt;=34 weeks' gestation: cost‐effectiveness analyses. Pediatrics1999;103(3):594‐8. ">Thureen 1999</a>; <a href="./references#CD005091-bbs2-0043" title="BajajM , PalmerK . Gentamicin usage in newborns‐‐a simple and practical regime. Pharmacy World &amp; Science2004;26(4):242‐4. ">Bajaj 2004</a>). As the great majority of infants treated with gentamicin are treated only for a short time (48 to 72 hours) until deep infection is excluded, this would increase the cost and complexity of their care with no clinical benefit. Therefore, the use of a reliable dosage regimen which then ensures maximum pharmacokinetic efficacy would be beneficial. Although our review was unable to demonstrate superior clinical efficacy of 'once a day' gentamicin, the superiority of 'once a day' gentamicin in achieving less pharmacokinetic failures suggested therapeutic drug monitoring may not be required if gentamicin is used for a short time. </p> <p>Five out of seven infants of less than 32 weeks' gestation developed toxic trough levels of more than 2 µg/ml. This occurred in both 'once a day' and 'multiple doses a day' regimens indicating that even a 'once a day' regimen may also be toxic in preterm neonates. The possible explanation is that very preterm infants have lower glomerular filtration rates and hence clear gentamicin more slowly than the more mature infants. In a recent retrospective study of 993 newborn infants, more than 20% in a group of preterm infants born between 28 and 31 weeks of gestation receiving 'once a day' gentamicin had an elevated trough level of more than 2 µg/ml; while infants born at less than 28 weeks and more than 35 weeks of gestation who received 36‐hourly and 24‐hourly gentamicin respectively had very low rates of elevated trough levels. Furthermore, indomethacin co‐administration resulted in a significantly higher median gentamicin level compared to infants of similar gestation who did not receive indomethacin (<a href="./references#CD005091-bbs2-0074" title="KönigK , LimA , MillerA , SakerS , GuyKJ , BarfieldCP . Gentamicin trough levels using a simplified extended‐interval dosing regimen in preterm and term newborn. European Journal of Pediatrics2014;174(5):669‐73. [PUBMED: 25388408] ">König 2015</a>). There are several studies evaluating factors influencing gentamicin pharmacokinetics in neonates. <a href="./references#CD005091-bbs2-0057" title="FuchsA , GuidiM , GiannoniE , WernerD , BuclinT , WidmerN , et al. Population pharmacokinetic study of gentamicin in a large cohort of premature and term neonates. British Journal of Clinical Pharmacology2014;78(5):1090‐101. [PUBMED: 24938850] ">Fuchs 2014</a>, an observational study including 3039 neonates, found that body weight and age are the most important factors affecting gentamicin dosage. Another recent population pharmacokinetics study described gentamicin pharmacokinetics in the newborn and, finding creatinine clearance a more important predictor of elimination of gentamicin in preterm infants, proposed 48‐hourly dosing for those neonates less than 32 weeks of gestational age (<a href="./references#CD005091-bbs2-0060" title="GarcíaB , BarciaE , PérezF , MolinaIT . Population pharmacokinetics of gentamicin in premature newborns. Journal of Antimicrobial Chemotherapy2006;58(2):372‐9. [PUBMED: 16782742] ">García 2006</a>). Evidence is accumulating that an extended dosing regimen of once in 36 to 48 hours may be more suitable for very preterm infants (less than 32 weeks' gestation) (<a href="http://archie.cochrane.org/sections/documents/view?version=05CA337082E26AA201A2F2795EE81913%26format=REVMAN#STD-Rastogi--2002#STD-Rastogi--2002" target="_blank">Rastogi 2002</a>; <a href="./references#CD005091-bbs2-0019" title="HansenA , ForbesP , ArnoldA , O'RourkeE . Once‐daily gentamicin dosing for the preterm and term newborn: proposal for a simple regimen that achieves target levels. Journal of Perinatology2003;23(8):635‐9. ">Hansen 2003</a>; <a href="./references#CD005091-bbs2-0030" title="MercadoMC , BrodskyNL , McGuireMK , HurtH . Extended interval dosing of gentamicin in preterm infants. American Journal of Perinatology2004;21(2):73‐7. ">Mercado 2004</a>; <a href="./references#CD005091-bbs2-0037" title="ThingvollES , GuilletR , CasertaM , DicenzoR . Observational trial of a 48‐hour gentamicin dosing regimen derived from Monte Carlo simulations in infants born at less than 28 weeks' gestation. Journal of Pediatrics2008;153(4):530‐4. ">Thingvoll 2008</a>; <a href="./references#CD005091-bbs2-0060" title="GarcíaB , BarciaE , PérezF , MolinaIT . Population pharmacokinetics of gentamicin in premature newborns. Journal of Antimicrobial Chemotherapy2006;58(2):372‐9. [PUBMED: 16782742] ">García 2006</a>; <a href="./references#CD005091-bbs2-0074" title="KönigK , LimA , MillerA , SakerS , GuyKJ , BarfieldCP . Gentamicin trough levels using a simplified extended‐interval dosing regimen in preterm and term newborn. European Journal of Pediatrics2014;174(5):669‐73. [PUBMED: 25388408] ">König 2015</a>; <a href="./references#CD005091-bbs2-0077" title="Lulic‐BoticaM , SheerT , EdwardsD , ThomasRL , NatarajanG . Impact of small‐for‐gestation age (SGA) status on gentamicin pharmacokinetics in neonates. Pediatric Pharmacology2013;54(1):39‐45. [PUBMED: 24122736] ">Lulic‐Botica 2013</a>; <a href="./references#CD005091-bbs2-0093" title="ValitaloPAJ , van denAnkerJN , AllegaertK , deCockRFW , deHoongM , SimonsSHP , et al. Novel model‐based dosing guidelines for gentamicin and tobramycin in preterm and term neonates. Journal of Antimicrobial Chemotherapy2015;70(7):2074‐7. [PUBMED: 25766737] ">Valitalo 2015</a>; <a href="./references#CD005091-bbs2-0058" title="FullasF , PadomekMT , ThiemanCJ , VanGorpAE . Comparative evaluation of six extended‐interval gentamicin dosing regimens in premature and full‐term neonates. American Journal of Health‐System Pharmacy2011;68(1):52‐6. [PUBMED: 21164066] ">Fullas 2011</a>). </p> </section> <section id="CD005091-sec-0083"> <h3 class="title" id="CD005091-sec-0083">Overall completeness and applicability of evidence</h3> <p>There is some evidence to support the use of 'once a day' dosing of gentamicin in neonates. </p> </section> <section id="CD005091-sec-0084"> <h3 class="title" id="CD005091-sec-0084">Quality of the evidence</h3> <p>Overall, the quality of evidence was considered to be moderate on GRADE analysis, given the small sample size and unclear/high risk of bias in some of the domains in a few of the included studies. </p> </section> <section id="CD005091-sec-0085"> <h3 class="title" id="CD005091-sec-0085">Potential biases in the review process</h3> <p>None to our knowledge.</p> </section> <section id="CD005091-sec-0086"> <h3 class="title" id="CD005091-sec-0086">Agreements and disagreements with other studies or reviews</h3> <p>The findings of this review are similar to the meta‐analysis in neonates, older children and adults in that 'once a day' gentamicin appears to be comparable in its clinical efficacy, nephrotoxicity and ototoxicity to that of 'multiple doses a day' (<a href="./references#CD005091-bbs2-0044" title="BarzaM , IoannidisJP , CappelleriJC , LauJ . Single or multiple daily doses of aminoglycosides: a meta‐analysis. BMJ1996;312(7027):338‐45. ">Barza 1996</a>; <a href="./references#CD005091-bbs2-0051" title="Contopoulos‐IoannidisDG , GiotisND , BaliatsaDV , IoannidisJP . Extended‐interval aminoglycoside administration for children: a meta‐analysis. Pediatrics2004;114(1):e111‐8. ">Contopoulos‐Ioannidis 2004</a>; <a href="./references#CD005091-bbs2-0042" title="BaileyTC , LittleJR , LittenbergB , ReichleyRM , DunaganWC . A meta‐analysis of extended‐interval dosing versus multiple daily dosing of aminoglycosides. Clinical Infectious Diseases1997;24(5):786‐95. ">Bailey 1997</a>; <a href="./references#CD005091-bbs2-0040" title="AliMZ , GoetzMB . A meta‐analysis of the relative efficacy and toxicity of single daily dosing versus multiple daily dosing of aminoglycosides. Clinical Infectious Diseases1997;24(5):796‐809. [PUBMED: 9142772] ">Ali 1997</a>; <a href="./references#CD005091-bbs2-0080" title="MunckhofWJ , GraysonML , TurnidgeJD . A meta‐analysis of studies on the safety and efficacy of aminoglycosides given either once daily or as divided doses. Journal of Antimicrobial Chemotherapy1996;37(4):645‐63. ">Munckhof 1996</a>; <a href="./references#CD005091-bbs2-0081" title="NestaasE , BangstadHJ , SandvikL , WathneKO . Aminoglycoside extended interval dosing in neonates is safe and effective: a meta‐analysis. Archives of disease in childhood. Fetal and neonatal edition2005;90(4):F294‐300. [PUBMED: 15857879] ">Nestaas 2005</a>). </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD005091-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005091.pub4/media/CDSR/CD005091/urn:x-wiley:14651858:media:CD005091:CD005091-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005091.pub4/media/CDSR/CD005091/image_t/tCD005091-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram: review update" data-id="CD005091-fig-0001" src="/cdsr/doi/10.1002/14651858.CD005091.pub4/media/CDSR/CD005091/image_n/nCD005091-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram: review update</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005091.pub4/full#CD005091-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005091.pub4/media/CDSR/CD005091/image_n/nCD005091-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005091-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005091.pub4/media/CDSR/CD005091/urn:x-wiley:14651858:media:CD005091:CD005091-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005091.pub4/media/CDSR/CD005091/image_t/tCD005091-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD005091-fig-0002" src="/cdsr/doi/10.1002/14651858.CD005091.pub4/media/CDSR/CD005091/image_n/nCD005091-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005091.pub4/full#CD005091-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005091.pub4/media/CDSR/CD005091/image_n/nCD005091-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005091-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005091.pub4/media/CDSR/CD005091/urn:x-wiley:14651858:media:CD005091:CD005091-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005091.pub4/media/CDSR/CD005091/image_t/tCD005091-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 1 All studies comparing 'once a day' versus 'multiple doses a day' regimen, outcome: 1.1 Clearance of proven sepsis." data-id="CD005091-fig-0003" src="/cdsr/doi/10.1002/14651858.CD005091.pub4/media/CDSR/CD005091/image_n/nCD005091-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Forest plot of comparison: 1 All studies comparing 'once a day' versus 'multiple doses a day' regimen, outcome: 1.1 Clearance of proven sepsis. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005091.pub4/full#CD005091-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005091.pub4/media/CDSR/CD005091/image_n/nCD005091-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005091-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005091.pub4/media/CDSR/CD005091/urn:x-wiley:14651858:media:CD005091:CD005091-AFig-FIG04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005091.pub4/media/CDSR/CD005091/image_t/tCD005091-AFig-FIG04.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 1 All studies comparing 'once a day' versus 'multiple doses a day' regimen, outcome: 1.2 Failure to achieve peak levels of at least 5 microgram/ml." data-id="CD005091-fig-0004" src="/cdsr/doi/10.1002/14651858.CD005091.pub4/media/CDSR/CD005091/image_n/nCD005091-AFig-FIG04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 4</div> <div class="figure-caption"> <p>Forest plot of comparison: 1 All studies comparing 'once a day' versus 'multiple doses a day' regimen, outcome: 1.2 Failure to achieve peak levels of at least 5 microgram/ml. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005091.pub4/full#CD005091-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005091.pub4/media/CDSR/CD005091/image_n/nCD005091-AFig-FIG04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005091-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005091.pub4/media/CDSR/CD005091/urn:x-wiley:14651858:media:CD005091:CD005091-AFig-FIG05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005091.pub4/media/CDSR/CD005091/image_t/tCD005091-AFig-FIG05.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 1 All studies comparing 'once a day' versus 'multiple doses a day' regimen, outcome: 1.3 Failure to achieve trough levels of ≤ 2 microgram/ml." data-id="CD005091-fig-0005" src="/cdsr/doi/10.1002/14651858.CD005091.pub4/media/CDSR/CD005091/image_n/nCD005091-AFig-FIG05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 5</div> <div class="figure-caption"> <p>Forest plot of comparison: 1 All studies comparing 'once a day' versus 'multiple doses a day' regimen, outcome: 1.3 Failure to achieve trough levels of ≤ 2 microgram/ml. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005091.pub4/full#CD005091-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005091.pub4/media/CDSR/CD005091/image_n/nCD005091-AFig-FIG05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005091-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005091.pub4/media/CDSR/CD005091/urn:x-wiley:14651858:media:CD005091:CD005091-AFig-FIG06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005091.pub4/media/CDSR/CD005091/image_t/tCD005091-AFig-FIG06.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 1 All studies comparing 'once a day' versus 'multiple doses a day' regimen, outcome: 1.5 Nephrotoxicity." data-id="CD005091-fig-0006" src="/cdsr/doi/10.1002/14651858.CD005091.pub4/media/CDSR/CD005091/image_n/nCD005091-AFig-FIG06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 6</div> <div class="figure-caption"> <p>Forest plot of comparison: 1 All studies comparing 'once a day' versus 'multiple doses a day' regimen, outcome: 1.5 Nephrotoxicity. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005091.pub4/full#CD005091-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005091.pub4/media/CDSR/CD005091/image_n/nCD005091-AFig-FIG06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005091-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005091.pub4/media/CDSR/CD005091/urn:x-wiley:14651858:media:CD005091:CD005091-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005091.pub4/media/CDSR/CD005091/image_t/tCD005091-CMP-001-01.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 All studies comparing 'once a day' versus 'multiple doses a day' regimen, Outcome 1 Clearance of proven sepsis." data-id="CD005091-fig-0007" src="/cdsr/doi/10.1002/14651858.CD005091.pub4/media/CDSR/CD005091/image_n/nCD005091-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 All studies comparing 'once a day' versus 'multiple doses a day' regimen, Outcome 1 Clearance of proven sepsis. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005091.pub4/references#CD005091-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005091.pub4/media/CDSR/CD005091/image_n/nCD005091-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005091-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005091.pub4/media/CDSR/CD005091/urn:x-wiley:14651858:media:CD005091:CD005091-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005091.pub4/media/CDSR/CD005091/image_t/tCD005091-CMP-001-02.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 All studies comparing 'once a day' versus 'multiple doses a day' regimen, Outcome 2 Failure to achieve peak levels of at least 5 microgram/ml." data-id="CD005091-fig-0008" src="/cdsr/doi/10.1002/14651858.CD005091.pub4/media/CDSR/CD005091/image_n/nCD005091-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 All studies comparing 'once a day' versus 'multiple doses a day' regimen, Outcome 2 Failure to achieve peak levels of at least 5 microgram/ml. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005091.pub4/references#CD005091-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005091.pub4/media/CDSR/CD005091/image_n/nCD005091-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005091-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005091.pub4/media/CDSR/CD005091/urn:x-wiley:14651858:media:CD005091:CD005091-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005091.pub4/media/CDSR/CD005091/image_t/tCD005091-CMP-001-03.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 All studies comparing 'once a day' versus 'multiple doses a day' regimen, Outcome 3 Failure to achieve trough levels of &lt;= 2 microgram/ml." data-id="CD005091-fig-0009" src="/cdsr/doi/10.1002/14651858.CD005091.pub4/media/CDSR/CD005091/image_n/nCD005091-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 All studies comparing 'once a day' versus 'multiple doses a day' regimen, Outcome 3 Failure to achieve trough levels of &lt;= 2 microgram/ml. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005091.pub4/references#CD005091-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005091.pub4/media/CDSR/CD005091/image_n/nCD005091-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005091-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005091.pub4/media/CDSR/CD005091/urn:x-wiley:14651858:media:CD005091:CD005091-CMP-001-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005091.pub4/media/CDSR/CD005091/image_t/tCD005091-CMP-001-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 All studies comparing 'once a day' versus 'multiple doses a day' regimen, Outcome 4 Ototoxicity." data-id="CD005091-fig-0010" src="/cdsr/doi/10.1002/14651858.CD005091.pub4/media/CDSR/CD005091/image_n/nCD005091-CMP-001-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 All studies comparing 'once a day' versus 'multiple doses a day' regimen, Outcome 4 Ototoxicity. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005091.pub4/references#CD005091-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005091.pub4/media/CDSR/CD005091/image_n/nCD005091-CMP-001-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005091-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005091.pub4/media/CDSR/CD005091/urn:x-wiley:14651858:media:CD005091:CD005091-CMP-001-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005091.pub4/media/CDSR/CD005091/image_t/tCD005091-CMP-001-05.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 All studies comparing 'once a day' versus 'multiple doses a day' regimen, Outcome 5 Nephrotoxicity." data-id="CD005091-fig-0011" src="/cdsr/doi/10.1002/14651858.CD005091.pub4/media/CDSR/CD005091/image_n/nCD005091-CMP-001-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1 All studies comparing 'once a day' versus 'multiple doses a day' regimen, Outcome 5 Nephrotoxicity. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005091.pub4/references#CD005091-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005091.pub4/media/CDSR/CD005091/image_n/nCD005091-CMP-001-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005091-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005091.pub4/media/CDSR/CD005091/urn:x-wiley:14651858:media:CD005091:CD005091-CMP-001-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005091.pub4/media/CDSR/CD005091/image_t/tCD005091-CMP-001-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 All studies comparing 'once a day' versus 'multiple doses a day' regimen, Outcome 6 Treatment failure." data-id="CD005091-fig-0012" src="/cdsr/doi/10.1002/14651858.CD005091.pub4/media/CDSR/CD005091/image_n/nCD005091-CMP-001-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1 All studies comparing 'once a day' versus 'multiple doses a day' regimen, Outcome 6 Treatment failure. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005091.pub4/references#CD005091-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005091.pub4/media/CDSR/CD005091/image_n/nCD005091-CMP-001-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005091-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005091.pub4/media/CDSR/CD005091/urn:x-wiley:14651858:media:CD005091:CD005091-CMP-001-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005091.pub4/media/CDSR/CD005091/image_t/tCD005091-CMP-001-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 All studies comparing 'once a day' versus 'multiple doses a day' regimen, Outcome 7 Actual peak levels (µg/ml)." data-id="CD005091-fig-0013" src="/cdsr/doi/10.1002/14651858.CD005091.pub4/media/CDSR/CD005091/image_n/nCD005091-CMP-001-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.7</div> <div class="figure-caption"> <p>Comparison 1 All studies comparing 'once a day' versus 'multiple doses a day' regimen, Outcome 7 Actual peak levels (µg/ml). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005091.pub4/references#CD005091-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005091.pub4/media/CDSR/CD005091/image_n/nCD005091-CMP-001-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005091-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005091.pub4/media/CDSR/CD005091/urn:x-wiley:14651858:media:CD005091:CD005091-CMP-001-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005091.pub4/media/CDSR/CD005091/image_t/tCD005091-CMP-001-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 All studies comparing 'once a day' versus 'multiple doses a day' regimen, Outcome 8 Actual trough levels (µg/ml).." data-id="CD005091-fig-0014" src="/cdsr/doi/10.1002/14651858.CD005091.pub4/media/CDSR/CD005091/image_n/nCD005091-CMP-001-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.8</div> <div class="figure-caption"> <p>Comparison 1 All studies comparing 'once a day' versus 'multiple doses a day' regimen, Outcome 8 Actual trough levels (µg/ml).. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005091.pub4/references#CD005091-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005091.pub4/media/CDSR/CD005091/image_n/nCD005091-CMP-001-08.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD005091-tbl-0001"> <div class="table-heading"><span class="table-title"></span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>One dose per day compared with multiple doses per day of gentamicin for treatment of suspected or proven sepsis in neonates</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population: neonates</b> with suspected or proven sepsis </p> <p><b>Settings: neonatal intensive care units</b> </p> <p><b>Intervention: one dose per day gentamicin</b> </p> <p><b>Comparison: multiple doses per day gentamicin</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of Participants<br/> (studies)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Multiple doses per day of gentamicin</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>One dose per day gentamicin</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Clearance of proven</b> </p> <p><b>sepsis</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Actual risk: 17 per 17</b> </p> <p><b>(1000 per 1000)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Actual risk: 20 per 20</b> </p> <p><b>(1000 per 1000)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1</b>(0.84 to 1.19) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>37</p> <p>(3 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Very small sample size, high risk of bias in the domain of completeness of follow‐up in 2 studies, high risk of bias for random sequence generation and allocation concealment in one study. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Failure to</b> </p> <p><b>achieve peak levels of at least 5 microgram/ml</b> </p> <p>(measured 0.5 to one hour after administration of any dose of gentamicin)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Actual risk: 35 per 214</b> </p> <p><b>(164 per 1000)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Actual risk:</b> </p> <p><b>6 per 208</b> </p> <p><b>(29 per 1000)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.22 (0.11 to 0.47)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>422</p> <p>(9 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate sample size, high risk of selection bias in two studies; high risk of attrition bias in 3 studies. </p> <p>Narrow CIs around the effect size, very low P value for effect size</p> <p>estimate, no statistical heterogeneity</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Nephrotoxicity</b> </p> <p>(End of study period or before discharge)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>348</p> <p>(8 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None of the study infants developed nephrotoxicity.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Ototoxicity</b> </p> <p>(End of study period or before discharge)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Actual risk: 1 per 111</b> </p> <p><b>(9 per 1000)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Actual risk:</b> </p> <p><b>2 per 103</b> </p> <p><b>(19 per 1000)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.69</b> ( <b>0.18 to 16.25 )</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>214</p> <p>(5 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Small sample size. Unclear risk of selection bias and reporting bias and high risk of attrition bias in the included studies. </p> <p>Wide CIs around the effect size, P value for effect size is greater than 0.05.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Failure to</b> </p> <p><b>achieve trough levels of</b> ≤<b>2 microgram/ml</b> </p> <p>(measured within one hour prior to the administration of gentamicin on any day except the initial dose) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Actual risk: 92 per 259</b> </p> <p><b>(355 per 1000)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Actual risk: 31/244</b> </p> <p><b>(127 per 1000)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.38</b> </p> <p><b>(</b>0.27 to 0.55) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>503 (11 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate sample size, high risk of selection bias in 2 studies, high risk of attrition bias in 3 studies, high risk of reporting bias in 2 studies. </p> <p>Narrow CIs around the effect size, very low P value for effect size estimate, moderate heterogeneity </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk Ratio; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-title"></span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD005091.pub4/full#CD005091-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD005091-tbl-0002"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">All studies comparing 'once a day' versus 'multiple doses a day' regimen</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Clearance of proven sepsis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>37</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [‐0.19, 0.19]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Failure to achieve peak levels of at least 5 microgram/ml <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>422</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.22 [0.11, 0.47]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Failure to achieve trough levels of &lt;= 2 microgram/ml <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>503</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.38 [0.27, 0.55]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Ototoxicity <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>214</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.69 [0.18, 16.25]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Nephrotoxicity <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>348</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Treatment failure <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>37</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [‐0.19, 0.19]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Actual peak levels (µg/ml) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>440</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.58 [2.26, 2.89]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Actual trough levels (µg/ml). <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>440</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.57 [‐0.69, ‐0.44]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">All studies comparing 'once a day' versus 'multiple doses a day' regimen</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD005091.pub4/references#CD005091-tbl-0002">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD005091.pub4&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD005091-note-0004">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD005091-note-0006">فارسی</a> </li> <li class="section-language"> <a class="" href="pl#CD005091-note-0003">Polski</a> </li> <li class="section-language"> <a class="" href="pt#CD005091-note-0002">Português</a> </li> <li class="section-language"> <a class="" href="ru#CD005091-note-0001">Русский</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734739000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734739000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773542000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773471000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005091\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD005091\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005091\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD005091\x2epub4"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005091\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD005091\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005091\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD005091\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005091\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD005091\x2epub4"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005091\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD005091\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005091\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD005091\x2epub4"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005091\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD005091\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005091\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD005091\x2epub4"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=0TJL4CWK&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD005091.pub4&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD005091.pub4';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD005091.pub4/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD005091.pub4/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD005091.pub4%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740718205281"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD005091.pub4/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740718205285"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD005091.pub4/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918dcaa949f7f3fd',t:'MTc0MDcxODIwNS4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 